activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	177473	CHEMBL734029	Inhibition of Mitogen activated protein kinase kinase 7 beta	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	68.0	CHEMBL3530	Homo sapiens	Activity	%	68.0
	177473	CHEMBL734029	Inhibition of Mitogen activated protein kinase kinase 7 beta	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	68.0	CHEMBL3530	Homo sapiens	Activity	%	68.0
	178786	CHEMBL734029	Inhibition of Mitogen activated protein kinase kinase 7 beta	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	71.0	CHEMBL3530	Homo sapiens	Activity	%	71.0
	182533	CHEMBL734029	Inhibition of Mitogen activated protein kinase kinase 7 beta	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	101.0	CHEMBL3530	Homo sapiens	Activity	%	101.0
	616529	CHEMBL712097	Inhibition of MKK7-beta kinase at 100 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	86.0	CHEMBL3530	Homo sapiens	Control	%	86.0
	616568	CHEMBL712098	Inhibition of MKK7-beta kinase at 500 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	70.0	CHEMBL3530	Homo sapiens	Control	%	70.0
	915754	CHEMBL734030	Inhibition of human Mitogen activated protein kinase kinase 7 beta at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	129.0	CHEMBL3530	Homo sapiens	Activity	%	129.0
	931215	CHEMBL734030	Inhibition of human Mitogen activated protein kinase kinase 7 beta at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Activity	%	132.0	CHEMBL3530	Homo sapiens	Activity	%	132.0
	1489872	CHEMBL828059	Inhibition of mitogen activated protein kinase kinase 7 beta	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F		CHEMBL1788116	>	IC50	nM	10000.0	CHEMBL3530	Homo sapiens	IC50	uM	10.0
	1734165	CHEMBL854398	Residual activity at human MKK7-beta at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	2.0	CHEMBL3530	Homo sapiens	Activity	%	2.0
	1734170	CHEMBL862846	Inhibition of human MKK7beta	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	>	IC50	nM	10000.0	CHEMBL3530	Homo sapiens	IC50	uM	10.0
	1769407	CHEMBL910926	Inhibition of MKK7beta	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	1790078	CHEMBL855339	Percentage activity of human MKK7 beta in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	121.0	CHEMBL3530	Homo sapiens	Activity	%	121.0
	2025166	CHEMBL886991	Inhibition of human MKK7-beta at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	78.0	CHEMBL3530	Homo sapiens	Inhibition	%	78.0
	2025384	CHEMBL886991	Inhibition of human MKK7-beta at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	88.0	CHEMBL3530	Homo sapiens	Inhibition	%	88.0
	2025385	CHEMBL886991	Inhibition of human MKK7-beta at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	85.0	CHEMBL3530	Homo sapiens	Inhibition	%	85.0
	2025386	CHEMBL886991	Inhibition of human MKK7-beta at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	97.0	CHEMBL3530	Homo sapiens	Inhibition	%	97.0
	2147312	CHEMBL921997	Activity of human MKK7-beta kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	95.0	CHEMBL3530	Homo sapiens	Activity	%	95.0
	2153720	CHEMBL928287	Inhibition of MKK7-beta at 20 uM	B	CN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL409525	<	Inhibition	%	50.0	CHEMBL3530	Homo sapiens	Inhibition	%	50.0
	2153755	CHEMBL928287	Inhibition of MKK7-beta at 20 uM	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	<	Inhibition	%	50.0	CHEMBL3530	Homo sapiens	Inhibition	%	50.0
	2356948	CHEMBL955832	Inhibition of MKK7 at 1 uM relative to control	B	Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL504805	>	Inhibition	%	50.0	CHEMBL3530	Homo sapiens	INH	%	50.0
	2528944	CHEMBL985012	Inhibition of MKK7beta	B	O[C@H]1CC[C@H](c2n[nH]cc2-c2ccnc(NC3CCCC3)n2)CC1		CHEMBL507249	=	IC50	nM	860.0	CHEMBL3530	Homo sapiens	IC50	uM	0.86
	2721653	CHEMBL1057482	Inhibition of MKK7beta at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3530	Homo sapiens	INH	%	50.0
	2938480	CHEMBL1041385	Inhibition of MKK7 at 2 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	6.0	CHEMBL3530	Homo sapiens	INH	%	6.0
Not Active	2990116	CHEMBL1045287	Inhibition of MKK7 at 3 uM	B	Fc1cc(-c2cc[nH]/c(=N/c3ccc(-n4cnc(N5CCOCC5)n4)cc3)n2)cc(N2CCOCC2)c1		CHEMBL585951		Activity			CHEMBL3530	Homo sapiens	Activity		
	3213950	CHEMBL1114906	Inhibition of MAP2K7 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O	Outside typical range	CHEMBL1077739	=	Inhibition	%	-19.0	CHEMBL3530	Homo sapiens	INH	%	-19.0
	3358674	CHEMBL1174916	Inhibition of MKK7 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	11.0	CHEMBL3530	Homo sapiens	INH	%	11.0
	3359116	CHEMBL1174916	Inhibition of MKK7 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	5.4	CHEMBL3530	Homo sapiens	INH	%	5.4
	3446787	CHEMBL1249792	Inhibition of His-tagged human MKK7 expressed in Escherichia coli at 10 uM	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Inhibition	%	89.0	CHEMBL3530	Homo sapiens	INH	%	89.0
	3447282	CHEMBL1249792	Inhibition of His-tagged human MKK7 expressed in Escherichia coli at 10 uM	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	91.0	CHEMBL3530	Homo sapiens	INH	%	91.0
	5121170	CHEMBL1646199	Inhibition of human MKK7beta at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	126.0	CHEMBL3530	Homo sapiens	INH	%	126.0
	5243738	CHEMBL1685701	Inhibition of MKK7beta at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	103.0	CHEMBL3530	Homo sapiens	INH	%	103.0
	5243846	CHEMBL1686058	Inhibition of MKK7beta at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	95.0	CHEMBL3530	Homo sapiens	INH	%	95.0
	5243959	CHEMBL1685701	Inhibition of MKK7beta at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	98.0	CHEMBL3530	Homo sapiens	INH	%	98.0
	5244067	CHEMBL1686058	Inhibition of MKK7beta at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	52.0	CHEMBL3530	Homo sapiens	INH	%	52.0
	5244940	CHEMBL1685701	Inhibition of MKK7beta at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	99.0	CHEMBL3530	Homo sapiens	INH	%	99.0
	5245048	CHEMBL1686058	Inhibition of MKK7beta at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	81.0	CHEMBL3530	Homo sapiens	INH	%	81.0
	5245199	CHEMBL1685701	Inhibition of MKK7beta at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	111.0	CHEMBL3530	Homo sapiens	INH	%	111.0
	5246029	CHEMBL1686058	Inhibition of MKK7beta at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	108.0	CHEMBL3530	Homo sapiens	INH	%	108.0
	6262771	CHEMBL1798994	Inhibition of MKK7	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	>	IC50	nM	10000.0	CHEMBL3530	Homo sapiens	IC50	uM	10.0
	7567127	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7567586	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7568057	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	530.0	CHEMBL3530	Homo sapiens	Kd	nM	530.0
	7568525	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7568957	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7569100	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7569560	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7570032	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7570495	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7570922	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7571076	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7571533	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7572009	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7573057	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7573514	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7573990	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7574017	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7574425	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7575035	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7575496	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7575990	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7576398	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7577009	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7577504	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7577974	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7578379	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7579399	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7579873	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7580342	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7580745	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7580933	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7581318	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7581763	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7582234	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Kd	nM	4400.0	CHEMBL3530	Homo sapiens	Kd	nM	4400.0
	7582698	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7583098	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7583279	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7583676	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7584121	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7584592	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7585054	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7585458	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7585609	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7586017	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7586463	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7586934	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7587388	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7587570	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7587989	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7588442	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7588913	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7589535	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7589959	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	80.0	CHEMBL3530	Homo sapiens	Kd	nM	80.0
	7590426	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7590909	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7591508	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7591930	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7592433	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7592886	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7593475	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	27.0	CHEMBL3530	Homo sapiens	Kd	nM	27.0
	7593910	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7593940	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7594413	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7594865	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	5300.0	CHEMBL3530	Homo sapiens	Kd	nM	5300.0
	7595443	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7595919	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7596390	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7596837	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7597426	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	110.0	CHEMBL3530	Homo sapiens	Kd	nM	110.0
	7597899	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7598369	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3530	Homo sapiens	Kd	nM	10000.0
	7598811	CHEMBL1908419	Binding constant for MKK7 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	30.0	CHEMBL3530	Homo sapiens	Kd	nM	30.0
	7922699	CHEMBL1918447	Inhibition of human recombinant MAP2K7beta at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	19.0	CHEMBL3530	Homo sapiens	INH	%	19.0
	8004288	CHEMBL1943314	Inhibition of human MAP2K7 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL3530	Homo sapiens	INH	%	35.0
	8004289	CHEMBL1943314	Inhibition of human MAP2K7 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL3530	Homo sapiens	INH	%	35.0
	8004290	CHEMBL1943314	Inhibition of human MAP2K7 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL3530	Homo sapiens	INH	%	35.0
	8004291	CHEMBL1943314	Inhibition of human MAP2K7 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL3530	Homo sapiens	INH	%	35.0
	10839386	CHEMBL2014952	Inhibition of MAP2K7 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	15.0	CHEMBL3530	Homo sapiens	INH	%	15.0
	10867532	CHEMBL2027422	Inhibition of MKK7 at 2 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Inhibition	%	0.0	CHEMBL3530	Homo sapiens	INH	%	0.0
	10926108	CHEMBL2046203	Inhibition of human MKK7beta assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	120.0	CHEMBL3530	Homo sapiens	Activity	%	120.0
	10926109	CHEMBL2046203	Inhibition of human MKK7beta assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	99.0	CHEMBL3530	Homo sapiens	Activity	%	99.0
	12074687	CHEMBL2161408	Inhibition of MKK7b at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL3530	Homo sapiens	INH	%	50.0
	12094394	CHEMBL2166397	Inhibition of human MKK7beta at 10 uM	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	=	Inhibition	%	26.0	CHEMBL3530	Homo sapiens	INH	%	26.0
	12172343	CHEMBL2215906	Inhibition of MKK7 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	97.0	CHEMBL3530	Homo sapiens	Activity	%	97.0
	12205216	CHEMBL2217251	Inhibition of MEK7	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	IC50	nM	300.0	CHEMBL3530	Homo sapiens	IC50	nM	300.0
	12223869	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	88.0	CHEMBL3530	Homo sapiens	Residual Activity	%	88.0
	12223870	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	126.0	CHEMBL3530	Homo sapiens	Residual Activity	%	126.0
	12223871	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	104.0	CHEMBL3530	Homo sapiens	Residual Activity	%	104.0
	12223872	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	87.0	CHEMBL3530	Homo sapiens	Residual Activity	%	87.0
	12223873	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	100.0	CHEMBL3530	Homo sapiens	Residual Activity	%	100.0
	12223874	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	97.0	CHEMBL3530	Homo sapiens	Residual Activity	%	97.0
	12223875	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	89.0	CHEMBL3530	Homo sapiens	Residual Activity	%	89.0
	12223876	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	99.0	CHEMBL3530	Homo sapiens	Residual Activity	%	99.0
	12223877	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	109.0	CHEMBL3530	Homo sapiens	Residual Activity	%	109.0
	12223878	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	96.0	CHEMBL3530	Homo sapiens	Residual Activity	%	96.0
	12223879	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	97.0	CHEMBL3530	Homo sapiens	Residual Activity	%	97.0
	12223880	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	75.0	CHEMBL3530	Homo sapiens	Residual Activity	%	75.0
	12223881	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	94.0	CHEMBL3530	Homo sapiens	Residual Activity	%	94.0
	12223882	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	98.0	CHEMBL3530	Homo sapiens	Residual Activity	%	98.0
	12223883	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	73.0	CHEMBL3530	Homo sapiens	Residual Activity	%	73.0
	12223884	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	84.0	CHEMBL3530	Homo sapiens	Residual Activity	%	84.0
	12223885	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	108.0	CHEMBL3530	Homo sapiens	Residual Activity	%	108.0
	12223886	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	110.0	CHEMBL3530	Homo sapiens	Residual Activity	%	110.0
	12223887	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	90.0	CHEMBL3530	Homo sapiens	Residual Activity	%	90.0
	12223888	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	69.0	CHEMBL3530	Homo sapiens	Residual Activity	%	69.0
	12223889	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	104.0	CHEMBL3530	Homo sapiens	Residual Activity	%	104.0
	12223890	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	98.0	CHEMBL3530	Homo sapiens	Residual Activity	%	98.0
	12223891	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	112.0	CHEMBL3530	Homo sapiens	Residual Activity	%	112.0
	12223892	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	110.0	CHEMBL3530	Homo sapiens	Residual Activity	%	110.0
	12223893	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	122.0	CHEMBL3530	Homo sapiens	Residual Activity	%	122.0
	12223894	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	91.0	CHEMBL3530	Homo sapiens	Residual Activity	%	91.0
	12223895	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	113.0	CHEMBL3530	Homo sapiens	Residual Activity	%	113.0
	12223896	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	119.0	CHEMBL3530	Homo sapiens	Residual Activity	%	119.0
	12223897	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	144.0	CHEMBL3530	Homo sapiens	Residual Activity	%	144.0
	12223898	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	102.0	CHEMBL3530	Homo sapiens	Residual Activity	%	102.0
	12223899	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	111.0	CHEMBL3530	Homo sapiens	Residual Activity	%	111.0
	12223900	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	95.0	CHEMBL3530	Homo sapiens	Residual Activity	%	95.0
	12223901	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	112.0	CHEMBL3530	Homo sapiens	Residual Activity	%	112.0
	12223902	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	102.0	CHEMBL3530	Homo sapiens	Residual Activity	%	102.0
	12223903	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	113.0	CHEMBL3530	Homo sapiens	Residual Activity	%	113.0
	12223904	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	96.0	CHEMBL3530	Homo sapiens	Residual Activity	%	96.0
	12223905	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	109.0	CHEMBL3530	Homo sapiens	Residual Activity	%	109.0
	12223906	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	102.0	CHEMBL3530	Homo sapiens	Residual Activity	%	102.0
	12223907	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	107.0	CHEMBL3530	Homo sapiens	Residual Activity	%	107.0
	12223908	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	87.0	CHEMBL3530	Homo sapiens	Residual Activity	%	87.0
	12223909	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	120.0	CHEMBL3530	Homo sapiens	Residual Activity	%	120.0
	12223910	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	104.0	CHEMBL3530	Homo sapiens	Residual Activity	%	104.0
	12223911	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	52.0	CHEMBL3530	Homo sapiens	Residual Activity	%	52.0
	12223912	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	70.0	CHEMBL3530	Homo sapiens	Residual Activity	%	70.0
	12223913	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	93.0	CHEMBL3530	Homo sapiens	Residual Activity	%	93.0
	12223914	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	101.0	CHEMBL3530	Homo sapiens	Residual Activity	%	101.0
	12223915	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	88.0	CHEMBL3530	Homo sapiens	Residual Activity	%	88.0
	12223916	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	81.0	CHEMBL3530	Homo sapiens	Residual Activity	%	81.0
	12223917	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	66.0	CHEMBL3530	Homo sapiens	Residual Activity	%	66.0
	12223918	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	101.0	CHEMBL3530	Homo sapiens	Residual Activity	%	101.0
	12223919	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	89.0	CHEMBL3530	Homo sapiens	Residual Activity	%	89.0
	12223920	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	95.0	CHEMBL3530	Homo sapiens	Residual Activity	%	95.0
	12223921	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	43.0	CHEMBL3530	Homo sapiens	Residual Activity	%	43.0
	12223922	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	82.0	CHEMBL3530	Homo sapiens	Residual Activity	%	82.0
	12223923	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	83.0	CHEMBL3530	Homo sapiens	Residual Activity	%	83.0
	12223924	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	74.0	CHEMBL3530	Homo sapiens	Residual Activity	%	74.0
	12223925	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	92.0	CHEMBL3530	Homo sapiens	Residual Activity	%	92.0
	12223926	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	82.0	CHEMBL3530	Homo sapiens	Residual Activity	%	82.0
	12223927	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	87.0	CHEMBL3530	Homo sapiens	Residual Activity	%	87.0
	12223928	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	91.0	CHEMBL3530	Homo sapiens	Residual Activity	%	91.0
	12223929	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	95.0	CHEMBL3530	Homo sapiens	Residual Activity	%	95.0
	12223930	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	111.0	CHEMBL3530	Homo sapiens	Residual Activity	%	111.0
	12223931	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	94.0	CHEMBL3530	Homo sapiens	Residual Activity	%	94.0
	12223932	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	98.0	CHEMBL3530	Homo sapiens	Residual Activity	%	98.0
	12223933	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	117.0	CHEMBL3530	Homo sapiens	Residual Activity	%	117.0
	12223934	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	91.0	CHEMBL3530	Homo sapiens	Residual Activity	%	91.0
	12223935	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	92.0	CHEMBL3530	Homo sapiens	Residual Activity	%	92.0
	12223936	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	100.0	CHEMBL3530	Homo sapiens	Residual Activity	%	100.0
	12223937	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	96.0	CHEMBL3530	Homo sapiens	Residual Activity	%	96.0
	12223938	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	87.0	CHEMBL3530	Homo sapiens	Residual Activity	%	87.0
	12223939	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	76.0	CHEMBL3530	Homo sapiens	Residual Activity	%	76.0
	12223940	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	85.0	CHEMBL3530	Homo sapiens	Residual Activity	%	85.0
	12223941	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	79.0	CHEMBL3530	Homo sapiens	Residual Activity	%	79.0
	12223942	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	102.0	CHEMBL3530	Homo sapiens	Residual Activity	%	102.0
	12223943	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	86.0	CHEMBL3530	Homo sapiens	Residual Activity	%	86.0
	12223944	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	101.0	CHEMBL3530	Homo sapiens	Residual Activity	%	101.0
	12223945	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	96.0	CHEMBL3530	Homo sapiens	Residual Activity	%	96.0
	12223946	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	92.0	CHEMBL3530	Homo sapiens	Residual Activity	%	92.0
	12223947	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	90.0	CHEMBL3530	Homo sapiens	Residual Activity	%	90.0
	12223948	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	12.0	CHEMBL3530	Homo sapiens	Residual Activity	%	12.0
	12223949	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	93.0	CHEMBL3530	Homo sapiens	Residual Activity	%	93.0
	12223950	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	104.0	CHEMBL3530	Homo sapiens	Residual Activity	%	104.0
	12223951	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	87.0	CHEMBL3530	Homo sapiens	Residual Activity	%	87.0
	12223952	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	107.0	CHEMBL3530	Homo sapiens	Residual Activity	%	107.0
	12223953	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	82.0	CHEMBL3530	Homo sapiens	Residual Activity	%	82.0
	12223954	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	89.0	CHEMBL3530	Homo sapiens	Residual Activity	%	89.0
	12223955	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	99.0	CHEMBL3530	Homo sapiens	Residual Activity	%	99.0
	12223956	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	86.0	CHEMBL3530	Homo sapiens	Residual Activity	%	86.0
	12223957	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	106.0	CHEMBL3530	Homo sapiens	Residual Activity	%	106.0
	12223958	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	52.0	CHEMBL3530	Homo sapiens	Residual Activity	%	52.0
	12223959	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	81.0	CHEMBL3530	Homo sapiens	Residual Activity	%	81.0
	12223960	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	88.0	CHEMBL3530	Homo sapiens	Residual Activity	%	88.0
	12223961	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	72.0	CHEMBL3530	Homo sapiens	Residual Activity	%	72.0
	12223962	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	11.0	CHEMBL3530	Homo sapiens	Residual Activity	%	11.0
	12223963	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	77.0	CHEMBL3530	Homo sapiens	Residual Activity	%	77.0
	12223964	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	85.0	CHEMBL3530	Homo sapiens	Residual Activity	%	85.0
	12223965	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	108.0	CHEMBL3530	Homo sapiens	Residual Activity	%	108.0
	12223966	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	93.0	CHEMBL3530	Homo sapiens	Residual Activity	%	93.0
	12223967	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	74.0	CHEMBL3530	Homo sapiens	Residual Activity	%	74.0
	12226337	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	95.0	CHEMBL3530	Homo sapiens	Residual Activity	%	95.0
	12226338	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	42.0	CHEMBL3530	Homo sapiens	Residual Activity	%	42.0
	12226339	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	7.0	CHEMBL3530	Homo sapiens	Residual Activity	%	7.0
	12226340	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	106.0	CHEMBL3530	Homo sapiens	Residual Activity	%	106.0
	12226341	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	100.0	CHEMBL3530	Homo sapiens	Residual Activity	%	100.0
	12226342	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	73.0	CHEMBL3530	Homo sapiens	Residual Activity	%	73.0
	12226343	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	91.0	CHEMBL3530	Homo sapiens	Residual Activity	%	91.0
	12226344	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	75.0	CHEMBL3530	Homo sapiens	Residual Activity	%	75.0
	12226345	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	91.0	CHEMBL3530	Homo sapiens	Residual Activity	%	91.0
	12226346	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	98.0	CHEMBL3530	Homo sapiens	Residual Activity	%	98.0
	12226347	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	95.0	CHEMBL3530	Homo sapiens	Residual Activity	%	95.0
	12226348	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	101.0	CHEMBL3530	Homo sapiens	Residual Activity	%	101.0
	12226349	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	100.0	CHEMBL3530	Homo sapiens	Residual Activity	%	100.0
	12226350	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	91.0	CHEMBL3530	Homo sapiens	Residual Activity	%	91.0
	12226351	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	88.0	CHEMBL3530	Homo sapiens	Residual Activity	%	88.0
	12226352	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	94.0	CHEMBL3530	Homo sapiens	Residual Activity	%	94.0
	12226353	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	101.0	CHEMBL3530	Homo sapiens	Residual Activity	%	101.0
	12226354	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	96.0	CHEMBL3530	Homo sapiens	Residual Activity	%	96.0
	12226355	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	101.0	CHEMBL3530	Homo sapiens	Residual Activity	%	101.0
	12226356	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	92.0	CHEMBL3530	Homo sapiens	Residual Activity	%	92.0
	12226357	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	82.0	CHEMBL3530	Homo sapiens	Residual Activity	%	82.0
	12226358	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	116.0	CHEMBL3530	Homo sapiens	Residual Activity	%	116.0
	12226359	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	86.0	CHEMBL3530	Homo sapiens	Residual Activity	%	86.0
	12226360	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	80.0	CHEMBL3530	Homo sapiens	Residual Activity	%	80.0
	12226361	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	70.0	CHEMBL3530	Homo sapiens	Residual Activity	%	70.0
	12226362	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	54.0	CHEMBL3530	Homo sapiens	Residual Activity	%	54.0
	12226363	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	100.0	CHEMBL3530	Homo sapiens	Residual Activity	%	100.0
	12226364	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	75.0	CHEMBL3530	Homo sapiens	Residual Activity	%	75.0
	12226365	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	91.0	CHEMBL3530	Homo sapiens	Residual Activity	%	91.0
	12226366	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	90.0	CHEMBL3530	Homo sapiens	Residual Activity	%	90.0
	12226367	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	65.0	CHEMBL3530	Homo sapiens	Residual Activity	%	65.0
	12226368	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	86.0	CHEMBL3530	Homo sapiens	Residual Activity	%	86.0
	12226369	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	87.0	CHEMBL3530	Homo sapiens	Residual Activity	%	87.0
	12226370	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	58.0	CHEMBL3530	Homo sapiens	Residual Activity	%	58.0
	12226371	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	67.0	CHEMBL3530	Homo sapiens	Residual Activity	%	67.0
	12226372	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	80.0	CHEMBL3530	Homo sapiens	Residual Activity	%	80.0
	12226373	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	95.0	CHEMBL3530	Homo sapiens	Residual Activity	%	95.0
	12226374	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	88.0	CHEMBL3530	Homo sapiens	Residual Activity	%	88.0
	12226375	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	56.0	CHEMBL3530	Homo sapiens	Residual Activity	%	56.0
	12226376	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	80.0	CHEMBL3530	Homo sapiens	Residual Activity	%	80.0
	12226377	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	84.0	CHEMBL3530	Homo sapiens	Residual Activity	%	84.0
	12226378	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	88.0	CHEMBL3530	Homo sapiens	Residual Activity	%	88.0
	12226379	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	84.0	CHEMBL3530	Homo sapiens	Residual Activity	%	84.0
	12226380	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	87.0	CHEMBL3530	Homo sapiens	Residual Activity	%	87.0
	12226381	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	90.0	CHEMBL3530	Homo sapiens	Residual Activity	%	90.0
	12226382	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	91.0	CHEMBL3530	Homo sapiens	Residual Activity	%	91.0
	12226383	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	84.0	CHEMBL3530	Homo sapiens	Residual Activity	%	84.0
	12226384	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	83.0	CHEMBL3530	Homo sapiens	Residual Activity	%	83.0
	12226385	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	67.0	CHEMBL3530	Homo sapiens	Residual Activity	%	67.0
	12226386	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	84.0	CHEMBL3530	Homo sapiens	Residual Activity	%	84.0
	12226387	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	82.0	CHEMBL3530	Homo sapiens	Residual Activity	%	82.0
	12226388	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	71.0	CHEMBL3530	Homo sapiens	Residual Activity	%	71.0
	12226389	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	106.0	CHEMBL3530	Homo sapiens	Residual Activity	%	106.0
	12226390	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	102.0	CHEMBL3530	Homo sapiens	Residual Activity	%	102.0
	12226391	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	100.0	CHEMBL3530	Homo sapiens	Residual Activity	%	100.0
	12226392	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	88.0	CHEMBL3530	Homo sapiens	Residual Activity	%	88.0
	12226393	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	73.0	CHEMBL3530	Homo sapiens	Residual Activity	%	73.0
	12226394	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	80.0	CHEMBL3530	Homo sapiens	Residual Activity	%	80.0
	12226395	CHEMBL2219269	Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	83.0	CHEMBL3530	Homo sapiens	Residual Activity	%	83.0
	12226396	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	102.0	CHEMBL3530	Homo sapiens	Residual Activity	%	102.0
	12226397	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	117.0	CHEMBL3530	Homo sapiens	Residual Activity	%	117.0
	12226398	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	106.0	CHEMBL3530	Homo sapiens	Residual Activity	%	106.0
	12226399	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	99.0	CHEMBL3530	Homo sapiens	Residual Activity	%	99.0
	12226400	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	93.0	CHEMBL3530	Homo sapiens	Residual Activity	%	93.0
	12226401	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	94.0	CHEMBL3530	Homo sapiens	Residual Activity	%	94.0
	12226402	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	59.0	CHEMBL3530	Homo sapiens	Residual Activity	%	59.0
	12226403	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	94.0	CHEMBL3530	Homo sapiens	Residual Activity	%	94.0
	12226404	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	110.0	CHEMBL3530	Homo sapiens	Residual Activity	%	110.0
	12226405	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	74.0	CHEMBL3530	Homo sapiens	Residual Activity	%	74.0
	12226406	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	90.0	CHEMBL3530	Homo sapiens	Residual Activity	%	90.0
	12226407	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	87.0	CHEMBL3530	Homo sapiens	Residual Activity	%	87.0
	12226408	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	89.0	CHEMBL3530	Homo sapiens	Residual Activity	%	89.0
	12226409	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	94.0	CHEMBL3530	Homo sapiens	Residual Activity	%	94.0
	12226410	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	38.0	CHEMBL3530	Homo sapiens	Residual Activity	%	38.0
	12226411	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	85.0	CHEMBL3530	Homo sapiens	Residual Activity	%	85.0
	12226412	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	107.0	CHEMBL3530	Homo sapiens	Residual Activity	%	107.0
	12226413	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	71.0	CHEMBL3530	Homo sapiens	Residual Activity	%	71.0
	12226414	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	73.0	CHEMBL3530	Homo sapiens	Residual Activity	%	73.0
	12226415	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	35.0	CHEMBL3530	Homo sapiens	Residual Activity	%	35.0
	12226416	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	81.0	CHEMBL3530	Homo sapiens	Residual Activity	%	81.0
	12226417	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	97.0	CHEMBL3530	Homo sapiens	Residual Activity	%	97.0
	12226418	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	84.0	CHEMBL3530	Homo sapiens	Residual Activity	%	84.0
	12226419	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	86.0	CHEMBL3530	Homo sapiens	Residual Activity	%	86.0
	12226420	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	100.0	CHEMBL3530	Homo sapiens	Residual Activity	%	100.0
	12226421	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	72.0	CHEMBL3530	Homo sapiens	Residual Activity	%	72.0
	12226422	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	63.0	CHEMBL3530	Homo sapiens	Residual Activity	%	63.0
	12226423	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	94.0	CHEMBL3530	Homo sapiens	Residual Activity	%	94.0
	12226424	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	111.0	CHEMBL3530	Homo sapiens	Residual Activity	%	111.0
	12226425	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	121.0	CHEMBL3530	Homo sapiens	Residual Activity	%	121.0
	12226426	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	87.0	CHEMBL3530	Homo sapiens	Residual Activity	%	87.0
	12226427	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	60.0	CHEMBL3530	Homo sapiens	Residual Activity	%	60.0
	12226428	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	112.0	CHEMBL3530	Homo sapiens	Residual Activity	%	112.0
	12226429	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	94.0	CHEMBL3530	Homo sapiens	Residual Activity	%	94.0
	12226430	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	80.0	CHEMBL3530	Homo sapiens	Residual Activity	%	80.0
	12226431	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	38.0	CHEMBL3530	Homo sapiens	Residual Activity	%	38.0
	12226432	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	131.0	CHEMBL3530	Homo sapiens	Residual Activity	%	131.0
	12226433	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	102.0	CHEMBL3530	Homo sapiens	Residual Activity	%	102.0
	12226434	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	83.0	CHEMBL3530	Homo sapiens	Residual Activity	%	83.0
	12226435	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	81.0	CHEMBL3530	Homo sapiens	Residual Activity	%	81.0
	12226436	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	118.0	CHEMBL3530	Homo sapiens	Residual Activity	%	118.0
	12226437	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	96.0	CHEMBL3530	Homo sapiens	Residual Activity	%	96.0
	12226438	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	34.0	CHEMBL3530	Homo sapiens	Residual Activity	%	34.0
	12226439	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	19.0	CHEMBL3530	Homo sapiens	Residual Activity	%	19.0
	12226440	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	87.0	CHEMBL3530	Homo sapiens	Residual Activity	%	87.0
	12226441	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	94.0	CHEMBL3530	Homo sapiens	Residual Activity	%	94.0
	12226442	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	82.0	CHEMBL3530	Homo sapiens	Residual Activity	%	82.0
	12226443	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	88.0	CHEMBL3530	Homo sapiens	Residual Activity	%	88.0
	12226444	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	39.0	CHEMBL3530	Homo sapiens	Residual Activity	%	39.0
	12226445	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	109.0	CHEMBL3530	Homo sapiens	Residual Activity	%	109.0
	12226446	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	104.0	CHEMBL3530	Homo sapiens	Residual Activity	%	104.0
	12226447	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	79.0	CHEMBL3530	Homo sapiens	Residual Activity	%	79.0
	12226448	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	12.0	CHEMBL3530	Homo sapiens	Residual Activity	%	12.0
	12226449	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	97.0	CHEMBL3530	Homo sapiens	Residual Activity	%	97.0
	12226450	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	68.0	CHEMBL3530	Homo sapiens	Residual Activity	%	68.0
	12226451	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	86.0	CHEMBL3530	Homo sapiens	Residual Activity	%	86.0
	12226452	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	74.0	CHEMBL3530	Homo sapiens	Residual Activity	%	74.0
	12226453	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	90.0	CHEMBL3530	Homo sapiens	Residual Activity	%	90.0
	12226454	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	67.0	CHEMBL3530	Homo sapiens	Residual Activity	%	67.0
	12226455	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	76.0	CHEMBL3530	Homo sapiens	Residual Activity	%	76.0
	12226456	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	61.0	CHEMBL3530	Homo sapiens	Residual Activity	%	61.0
	12226457	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	135.0	CHEMBL3530	Homo sapiens	Residual Activity	%	135.0
	12226458	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	103.0	CHEMBL3530	Homo sapiens	Residual Activity	%	103.0
	12226459	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	85.0	CHEMBL3530	Homo sapiens	Residual Activity	%	85.0
	12226460	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	101.0	CHEMBL3530	Homo sapiens	Residual Activity	%	101.0
	12226461	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	84.0	CHEMBL3530	Homo sapiens	Residual Activity	%	84.0
	12226462	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	88.0	CHEMBL3530	Homo sapiens	Residual Activity	%	88.0
	12226463	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	79.0	CHEMBL3530	Homo sapiens	Residual Activity	%	79.0
	12226464	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	88.0	CHEMBL3530	Homo sapiens	Residual Activity	%	88.0
	12226465	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	81.0	CHEMBL3530	Homo sapiens	Residual Activity	%	81.0
	12226466	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	93.0	CHEMBL3530	Homo sapiens	Residual Activity	%	93.0
	12226467	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	87.0	CHEMBL3530	Homo sapiens	Residual Activity	%	87.0
	12226468	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	96.0	CHEMBL3530	Homo sapiens	Residual Activity	%	96.0
	12226469	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	85.0	CHEMBL3530	Homo sapiens	Residual Activity	%	85.0
	12226470	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	71.0	CHEMBL3530	Homo sapiens	Residual Activity	%	71.0
	12226471	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	93.0	CHEMBL3530	Homo sapiens	Residual Activity	%	93.0
	12226472	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	99.0	CHEMBL3530	Homo sapiens	Residual Activity	%	99.0
	12226473	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	81.0	CHEMBL3530	Homo sapiens	Residual Activity	%	81.0
	12226474	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	90.0	CHEMBL3530	Homo sapiens	Residual Activity	%	90.0
	12226475	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL3530	Homo sapiens	Residual Activity	%	1.0
	12226476	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	107.0	CHEMBL3530	Homo sapiens	Residual Activity	%	107.0
	12226477	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	91.0	CHEMBL3530	Homo sapiens	Residual Activity	%	91.0
	12226478	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	86.0	CHEMBL3530	Homo sapiens	Residual Activity	%	86.0
	12226479	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	121.0	CHEMBL3530	Homo sapiens	Residual Activity	%	121.0
	12226480	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	95.0	CHEMBL3530	Homo sapiens	Residual Activity	%	95.0
	12226481	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	85.0	CHEMBL3530	Homo sapiens	Residual Activity	%	85.0
	12226482	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	48.0	CHEMBL3530	Homo sapiens	Residual Activity	%	48.0
	12226483	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	68.0	CHEMBL3530	Homo sapiens	Residual Activity	%	68.0
	12226484	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	82.0	CHEMBL3530	Homo sapiens	Residual Activity	%	82.0
	12226485	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	7.0	CHEMBL3530	Homo sapiens	Residual Activity	%	7.0
	12226486	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	90.0	CHEMBL3530	Homo sapiens	Residual Activity	%	90.0
	12226487	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	70.0	CHEMBL3530	Homo sapiens	Residual Activity	%	70.0
	12226488	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	58.0	CHEMBL3530	Homo sapiens	Residual Activity	%	58.0
	12226489	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	4.0	CHEMBL3530	Homo sapiens	Residual Activity	%	4.0
	12226490	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	22.0	CHEMBL3530	Homo sapiens	Residual Activity	%	22.0
	12226491	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	97.0	CHEMBL3530	Homo sapiens	Residual Activity	%	97.0
	12226492	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	96.0	CHEMBL3530	Homo sapiens	Residual Activity	%	96.0
	12226493	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	77.0	CHEMBL3530	Homo sapiens	Residual Activity	%	77.0
	12226494	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	101.0	CHEMBL3530	Homo sapiens	Residual Activity	%	101.0
	12226495	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	101.0	CHEMBL3530	Homo sapiens	Residual Activity	%	101.0
	12226496	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	27.0	CHEMBL3530	Homo sapiens	Residual Activity	%	27.0
	12226497	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL3530	Homo sapiens	Residual Activity	%	0.0
	12226498	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	84.0	CHEMBL3530	Homo sapiens	Residual Activity	%	84.0
	12226499	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	98.0	CHEMBL3530	Homo sapiens	Residual Activity	%	98.0
	12226500	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	89.0	CHEMBL3530	Homo sapiens	Residual Activity	%	89.0
	12226501	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	75.0	CHEMBL3530	Homo sapiens	Residual Activity	%	75.0
	12226502	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	90.0	CHEMBL3530	Homo sapiens	Residual Activity	%	90.0
	12226503	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	97.0	CHEMBL3530	Homo sapiens	Residual Activity	%	97.0
	12226504	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	96.0	CHEMBL3530	Homo sapiens	Residual Activity	%	96.0
	12226505	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	62.0	CHEMBL3530	Homo sapiens	Residual Activity	%	62.0
	12226506	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	98.0	CHEMBL3530	Homo sapiens	Residual Activity	%	98.0
	12226507	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	103.0	CHEMBL3530	Homo sapiens	Residual Activity	%	103.0
	12226508	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	107.0	CHEMBL3530	Homo sapiens	Residual Activity	%	107.0
	12226509	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	77.0	CHEMBL3530	Homo sapiens	Residual Activity	%	77.0
	12226510	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	103.0	CHEMBL3530	Homo sapiens	Residual Activity	%	103.0
	12226511	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	104.0	CHEMBL3530	Homo sapiens	Residual Activity	%	104.0
	12226512	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	44.0	CHEMBL3530	Homo sapiens	Residual Activity	%	44.0
	12226513	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	73.0	CHEMBL3530	Homo sapiens	Residual Activity	%	73.0
	12226514	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	99.0	CHEMBL3530	Homo sapiens	Residual Activity	%	99.0
	12226515	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	83.0	CHEMBL3530	Homo sapiens	Residual Activity	%	83.0
	12226516	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	79.0	CHEMBL3530	Homo sapiens	Residual Activity	%	79.0
	12226517	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	91.0	CHEMBL3530	Homo sapiens	Residual Activity	%	91.0
	12226518	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	93.0	CHEMBL3530	Homo sapiens	Residual Activity	%	93.0
	12226519	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	94.0	CHEMBL3530	Homo sapiens	Residual Activity	%	94.0
	12226520	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	5.0	CHEMBL3530	Homo sapiens	Residual Activity	%	5.0
	12226521	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	70.0	CHEMBL3530	Homo sapiens	Residual Activity	%	70.0
	12226522	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	108.0	CHEMBL3530	Homo sapiens	Residual Activity	%	108.0
	12226523	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	93.0	CHEMBL3530	Homo sapiens	Residual Activity	%	93.0
	12226524	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	96.0	CHEMBL3530	Homo sapiens	Residual Activity	%	96.0
	12226525	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	16.0	CHEMBL3530	Homo sapiens	Residual Activity	%	16.0
	12226526	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	95.0	CHEMBL3530	Homo sapiens	Residual Activity	%	95.0
	12226527	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	86.0	CHEMBL3530	Homo sapiens	Residual Activity	%	86.0
	12226528	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	6.0	CHEMBL3530	Homo sapiens	Residual Activity	%	6.0
	12226529	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	78.0	CHEMBL3530	Homo sapiens	Residual Activity	%	78.0
	12226530	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	70.0	CHEMBL3530	Homo sapiens	Residual Activity	%	70.0
	12226531	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	104.0	CHEMBL3530	Homo sapiens	Residual Activity	%	104.0
	12226532	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	81.0	CHEMBL3530	Homo sapiens	Residual Activity	%	81.0
	12226533	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	16.0	CHEMBL3530	Homo sapiens	Residual Activity	%	16.0
	12226534	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	93.0	CHEMBL3530	Homo sapiens	Residual Activity	%	93.0
	12226535	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	53.0	CHEMBL3530	Homo sapiens	Residual Activity	%	53.0
	12226536	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	96.0	CHEMBL3530	Homo sapiens	Residual Activity	%	96.0
	12226537	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	96.0	CHEMBL3530	Homo sapiens	Residual Activity	%	96.0
	12226538	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	46.0	CHEMBL3530	Homo sapiens	Residual Activity	%	46.0
	12226539	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	91.0	CHEMBL3530	Homo sapiens	Residual Activity	%	91.0
	12226540	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	95.0	CHEMBL3530	Homo sapiens	Residual Activity	%	95.0
	12226541	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	77.0	CHEMBL3530	Homo sapiens	Residual Activity	%	77.0
	12226542	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	105.0	CHEMBL3530	Homo sapiens	Residual Activity	%	105.0
	12226543	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	42.0	CHEMBL3530	Homo sapiens	Residual Activity	%	42.0
	12226544	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	79.0	CHEMBL3530	Homo sapiens	Residual Activity	%	79.0
	12226545	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	99.0	CHEMBL3530	Homo sapiens	Residual Activity	%	99.0
	12226546	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	16.0	CHEMBL3530	Homo sapiens	Residual Activity	%	16.0
	12226547	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	71.0	CHEMBL3530	Homo sapiens	Residual Activity	%	71.0
	12226548	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	98.0	CHEMBL3530	Homo sapiens	Residual Activity	%	98.0
	12226549	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	99.0	CHEMBL3530	Homo sapiens	Residual Activity	%	99.0
	12226550	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	82.0	CHEMBL3530	Homo sapiens	Residual Activity	%	82.0
	12226551	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	96.0	CHEMBL3530	Homo sapiens	Residual Activity	%	96.0
	12226552	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	57.0	CHEMBL3530	Homo sapiens	Residual Activity	%	57.0
	12226553	CHEMBL2219270	Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	74.0	CHEMBL3530	Homo sapiens	Residual Activity	%	74.0
	12693208	CHEMBL2343894	Inhibition of MKK7beta (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL3530	Homo sapiens	IC50	nM	10000.0
	13872095	CHEMBL3101403	Inhibition of human MKK7beta assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	103.0	CHEMBL3530	Homo sapiens	Activity	%	103.0
	13895026	CHEMBL3111958	Inhibition of MKK7 (unknown origin) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	O=C(Nc1ccc(CO)cc1)Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109142	=	Activity	%	91.0	CHEMBL3530	Homo sapiens	Activity	%	91.0
	13953312	CHEMBL3130916	Inhibition of human MKK7beta assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	94.0	CHEMBL3530	Homo sapiens	Activity	%	94.0
	13953325	CHEMBL3130916	Inhibition of human MKK7beta assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	92.0	CHEMBL3530	Homo sapiens	Activity	%	92.0
	13953356	CHEMBL3130916	Inhibition of human MKK7beta assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	88.0	CHEMBL3530	Homo sapiens	Activity	%	88.0
	14582553	CHEMBL3242554	Inhibition of human MKK7 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	121.0	CHEMBL3530	Homo sapiens	Activity	%	121.0
	14710316	CHEMBL3292193	Inhibition of human MKK7beta assessed as residual activity at 10 uM relative to control	B	CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3scc(-c4ccccc4)c23)C1=O		CHEMBL3290628	=	Activity	%	122.0	CHEMBL3530	Homo sapiens	Activity	%	122.0
	14710317	CHEMBL3292193	Inhibition of human MKK7beta assessed as residual activity at 10 uM relative to control	B	CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3scc(-c4cccc(OCCN5CCCCC5)c4)c23)C1=O.Cl		CHEMBL3290631	=	Activity	%	108.0	CHEMBL3530	Homo sapiens	Activity	%	108.0
	14991963	CHEMBL3373544	Inhibition of MAP2K7 (unknown origin) using unphosphorylated GST-tagged JNK1 substrate protein assessed as phosphorylation by ELISA	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	IC50	nM	1300.0	CHEMBL3530	Homo sapiens	IC50	uM	1.3
	15151376	CHEMBL3395591	Inhibition of MKK7 (unknown origin)	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)cc(N3CCC(F)(F)C3)n2)c1		CHEMBL3393333	>	IC50	nM	5000.0	CHEMBL3530	Homo sapiens	IC50	nM	5000.0
	15754955	CHEMBL3631847	Inhibition of MKK7 (unknown origin) using KFMMTPpYVVTR substrate incubated for 1 hr measured by MpTPpYV probe-based fluorescence polarization assay	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	>	IC50	nM	5000.0	CHEMBL3530	Homo sapiens	IC50	uM	5.0
	15756131	CHEMBL3631909	Inhibition of MKK7 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	22.7	CHEMBL3530	Homo sapiens	INH	%	22.7
	15757968	CHEMBL3631909	Inhibition of MKK7 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	7.17	CHEMBL3530	Homo sapiens	INH	%	7.17
	15759680	CHEMBL3631909	Inhibition of MKK7 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	2.0	CHEMBL3530	Homo sapiens	INH	%	2.0
	16360671	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(N4CCCCC4)c3c2c1		CHEMBL3719354	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360672	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cl.NC(=O)c1ccc2[nH]c3ncnc(N4CCCCC4)c3c2c1		CHEMBL3715588	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360673	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(N4CCOCC4)c3c2c1		CHEMBL3717948	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360674	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(N4CCC(O)CC4)c3c2c1		CHEMBL3718944	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360675	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(NC4CCCCCC4)c3c2c1		CHEMBL3715453	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360676	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC1CCN(c2ncnc3[nH]c4ccc(C(N)=O)cc4c23)CC1		CHEMBL3716162	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360677	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC1CCCN(c2ncnc3[nH]c4ccc(C(N)=O)cc4c23)C1		CHEMBL3719102	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360678	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC1CC(C)CN(c2ncnc3[nH]c4ccc(C(N)=O)cc4c23)C1		CHEMBL3718794	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360679	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cl.NC(=O)c1ccc2[nH]c3ncnc(N4CCOCC4)c3c2c1		CHEMBL3714972	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360680	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(N4CCCCC4CO)c3c2c1		CHEMBL3716261	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360681	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(NC4CCCC4)c3c2c1		CHEMBL3715699	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360682	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(N4CCCCCC4)c3c2c1		CHEMBL3715974	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360683	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cl.NCCNc1ncnc2[nH]c3ccc(C(N)=O)cc3c12		CHEMBL3717865	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360684	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(N4CCC(CCO)CC4)c3c2c1		CHEMBL3715809	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360685	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(NC4CCCCC4)c3c2c1		CHEMBL3719380	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360686	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(NCCO)c3c2c1		CHEMBL3716514	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360687	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CN(CCO)c1ncnc2[nH]c3ccc(C(N)=O)cc3c12		CHEMBL3717647	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360688	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(N4CCC(O)(Cc5ccccc5)CC4)c3c2c1		CHEMBL3716012	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360689	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(N4CCCC4)c3c2c1		CHEMBL3716716	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360690	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC(CO)Nc1ncnc2[nH]c3ccc(C(N)=O)cc3c12		CHEMBL3717209	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360691	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CCC1CCCCN1c1ncnc2[nH]c3ccc(C(N)=O)cc3c12		CHEMBL3715037	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360692	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(N4CCC(CO)CC4)c3c2c1		CHEMBL3717440	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360693	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cl.Cl.NC(=O)c1ccc2[nH]c3ncnc(N4CCCC(N)C4)c3c2c1		CHEMBL3715496	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360694	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC(C)(C)OC(=O)NC1CCCN(c2ncnc3[nH]c4ccc(C(N)=O)cc4c23)C1		CHEMBL3718545	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360695	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cl.Cl.NCCCNc1ncnc2[nH]c3ccc(C(N)=O)cc3c12		CHEMBL3716106	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360696	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC(C)(C)OC(=O)NCCNc1ncnc2[nH]c3ccc(C(N)=O)cc3c12		CHEMBL3717224	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360697	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cl.Cl.NC(=O)c1ccc2[nH]c3ncnc(N4CCC(N)C4)c3c2c1		CHEMBL3715371	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360698	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CCCN(CCC)c1ncnc2[nH]c3ccc(C(N)=O)cc3c12		CHEMBL3715062	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360699	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CNC1CCN(c2ncnc3[nH]c4ccc(C(N)=O)cc4c23)C1.Cl.Cl		CHEMBL3718973	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360700	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(N4CCC(C(=O)O)CC4)c3c2c1		CHEMBL3715499	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360701	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC(=O)NC1CCN(c2ncnc3[nH]c4ccc(C(N)=O)cc4c23)CC1		CHEMBL3717686	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360702	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(N(CCO)Cc4ccccc4)c3c2c1		CHEMBL3717711	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360703	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3nc(N)nc(N4CCCCC4)c3c2c1		CHEMBL3717493	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360704	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	COC(=O)c1ccc2[nH]c3nc(C)nc(N4CCCCC4)c3c2c1		CHEMBL3715766	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360705	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(N2CCCCC2)c2c(n1)[nH]c1ccc(C(=O)O)cc12		CHEMBL3718597	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360706	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(N2CCCCC2)c2c(n1)[nH]c1ccc(C(N)=O)cc12		CHEMBL3716812	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360707	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCCCCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3715015	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360708	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(NCCN2CCCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3717139	>	IC50	nM	10000.0	CHEMBL3530	Homo sapiens	IC50	uM	10.0
	16360709	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N(Cc2ccccc2)Cc2ccccc2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3718887	>	IC50	nM	10000.0	CHEMBL3530	Homo sapiens	IC50	uM	10.0
	16360710	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(NCc2ccccc2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3715932	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360711	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCC3(CC2)OCCO3)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3715207	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360712	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(NC2CCCCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3718936	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360713	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(NC2CCCCCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3718883	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360714	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(NC2CCCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3717128	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360715	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CN(Cc1ccccc1)c1nc(N)nc2[nH]c3ccc(O)cc3c12		CHEMBL3716981	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360716	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCC3CCCCC3C2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3717143	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360717	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CN(c1nc(N)nc2[nH]c3ccc(O)cc3c12)C1CCCCC1		CHEMBL3716642	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360718	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NCc1ccc2[nH]c3nc(N)nc(N4CCCCC4)c3c2c1		CHEMBL3715933	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360719	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC(=O)O.Nc1nc(N2CCOCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3716117	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360720	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC(=O)O.Nc1nc(N2CCCCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3715052	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360721	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	COc1ccc2[nH]c3nc(N)nc(N4CCOCC4)c3c2c1		CHEMBL3715113	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360722	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	COc1cc2[nH]c3nc(N)nc(N4CCOCC4)c3c2cc1OC		CHEMBL3715441	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360723	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	COc1cc2[nH]c3nc(N)nc(N4CCCCC4)c3c2cc1OC		CHEMBL3717892	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360724	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCNCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3718826	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360725	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3718705	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360726	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCOCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3719212	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360727	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCCCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3715629	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360728	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCC(Cc3ccccc3)CC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3715822	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360729	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCC(Br)CC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3719312	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360730	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC1CCN(c2nc(N)nc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3718589	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360731	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCCCC2)c2c(n1)[nH]c1ccc(Cl)cc12		CHEMBL3714913	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360732	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1ccc2[nH]c3nc(N)nc(N4CCCCC4)c3c2c1		CHEMBL3717409	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360733	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCC(C(=O)O)CC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3719327	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360734	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCC(N3CCCC3)CC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3715851	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360735	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(NCCO)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3718146	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360736	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCCCC2)c2c(n1)[nH]c1ccc(C(=O)O)cc12		CHEMBL3717233	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360737	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	COC(=O)c1ccc2[nH]c3nc(N)nc(N4CCCCC4)c3c2c1		CHEMBL3718020	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360738	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CN(CCO)c1nc(N)nc2[nH]c3ccc(O)cc3c12		CHEMBL3718209	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360739	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCC(O)CC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3718401	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360740	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC1CCCN(c2nc(N)nc3[nH]c4ccc(O)cc4c23)C1		CHEMBL3717494	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360741	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC1CCCCN1c1nc(N)nc2[nH]c3ccc(O)cc3c12		CHEMBL3717461	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360742	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	COC1CCN(c2nc(N)nc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3718118	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360743	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC(C)N(C)c1nc(N)nc2[nH]c3ccc(O)cc3c12		CHEMBL3716310	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360744	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Nc1nc(N2CCCC(O)C2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3717507	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360745	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(N4CCCCC4)c3c2c1		CHEMBL3718539	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360746	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(N4CCOCC4)c3c2c1		CHEMBL3718365	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360747	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(NC4CCCCC4)c3c2c1		CHEMBL3718526	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360748	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(N4CCCC4)c3c2c1		CHEMBL3717066	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360749	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CN(c1ncnc2[nH]c3ccc(O)cc3c12)C1CCCCC1		CHEMBL3715098	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360750	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CN(CCO)c1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3717665	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360751	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(N4CCC(O)CC4)c3c2c1		CHEMBL3715125	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360752	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	OCCNc1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3719169	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360753	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC1CCN(c2ncnc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3715894	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360754	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(N4CCCCCC4)c3c2c1		CHEMBL3714915	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360755	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC1CCCN(c2ncnc3[nH]c4ccc(O)cc4c23)C1		CHEMBL3718552	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360756	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	COCCNc1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3718123	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360757	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	OCC1CCN(c2ncnc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3716671	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360758	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	COC1CCN(c2ncnc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3715019	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360759	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(NC4CCCCCC4)c3c2c1		CHEMBL3719123	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360760	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC1CC(C)CN(c2ncnc3[nH]c4ccc(O)cc4c23)C1		CHEMBL3714792	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360761	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(N4CCCC(O)C4)c3c2c1		CHEMBL3717857	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360762	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	OC[C@@H]1CCCN1c1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3717708	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16360763	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(N4CCC(O)C4)c3c2c1		CHEMBL3714946	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361069	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CCC1CCCCN1c1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3715474	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361070	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC(C)N(C)c1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3718041	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361071	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC(CO)Nc1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3716618	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361072	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	OCC1CCCCN1c1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3718741	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361073	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	OCC1CCCN(c2ncnc3[nH]c4ccc(O)cc4c23)C1		CHEMBL3716792	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361074	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	O=C1CCN(c2ncnc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3718722	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361075	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(N[C@H]4CC[C@H](O)CC4)c3c2c1		CHEMBL3716988	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361076	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	O=C(O)CCCCCN1CCN(c2ncnc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3716342	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361077	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)C1CCN(c2ncnc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3718537	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361078	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	O=C(O)C1CCN(c2ncnc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3718663	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361079	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	OCCCCN1CCN(c2ncnc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3715650	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361080	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CN(C)c1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3718286	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361081	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(N4CCC(O)(Cc5ccccc5)CC4)c3c2c1		CHEMBL3714948	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361082	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(N4CCNCC4)c3c2c1		CHEMBL3717848	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361083	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(NC4CCCC4)c3c2c1		CHEMBL3716590	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361084	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cl.Oc1ccc2[nH]c3ncnc(N4CCCC(O)C4)c3c2c1		CHEMBL3716847	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361085	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(NCCc4c[nH]cn4)c3c2c1		CHEMBL3716269	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361086	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cl.Cl.N[C@H]1CCN(c2ncnc3[nH]c4ccc(O)cc4c23)C1		CHEMBL3716308	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361087	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cl.Cl.NC1CCCN(c2ncnc3[nH]c4ccc(O)cc4c23)C1		CHEMBL3715327	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361088	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC(C)(C)OC(=O)N1CCC(Nc2ncnc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3716098	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361089	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	O=CN1CCN(c2ncnc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3717278	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361090	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	OCCC1CCN(c2ncnc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3715419	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361091	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	OCCC1CCCCN1c1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3718228	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361092	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cl.Cl.NCCNc1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3715450	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361093	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CCN(CCO)c1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3719097	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361094	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)C1CCCN(c2ncnc3[nH]c4ccc(O)cc4c23)C1		CHEMBL3717897	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361095	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	OCCC1CCCN(c2ncnc3[nH]c4ccc(O)cc4c23)C1		CHEMBL3715000	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361096	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	OC[C@H](Cc1ccccc1)Nc1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3715845	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361097	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	C[C@H](CO)Nc1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3718444	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361098	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(NC4CCOCC4)c3c2c1		CHEMBL3717564	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361099	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC(O)CNc1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3715677	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361100	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	OCCN(CCO)c1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3715078	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361101	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	OCCCNc1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3718327	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361102	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	C[C@@H](CO)Nc1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3715671	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361103	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(N4CCCC(O)C4)c3c2c1		CHEMBL3715506	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361104	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC(C)(C)OC(=O)NC1CCN(c2ncnc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3715638	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361105	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cl.Cl.NC1CCN(c2ncnc3[nH]c4ccc(O)cc4c23)CC1		CHEMBL3716733	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361106	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	OCC1(Nc2ncnc3[nH]c4ccc(O)cc4c23)CCCC1		CHEMBL3715992	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361107	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(N4CCC[C@@H](O)C4)c3c2c1		CHEMBL3717088	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361108	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CC1CCCCN1c1ncnc2[nH]c3ccc(O)cc3c12		CHEMBL3717780	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361109	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(NC(C)CO)c2c(n1)[nH]c1ccc(OCc3ccccc3)cc12		CHEMBL3716627	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361110	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(NC(C)CO)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3718941	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361111	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(N2CCCCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3717291	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361112	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(N2CCC(C)CC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3715304	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361113	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(N2CCCCCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3719265	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361114	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(N2CCOCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3718455	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361115	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(N2CCCC(C)C2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3719173	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361116	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CNc1nc(C)nc2[nH]c3ccc(O)cc3c12		CHEMBL3715283	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361117	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(N2CCCCC2C)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3717316	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361118	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(N2CCCC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3718879	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361119	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CCN(CC)c1nc(C)nc2[nH]c3ccc(O)cc3c12		CHEMBL3718605	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361120	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(NCCO)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3718009	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361121	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(N2CCC(CO)CC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3716916	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361122	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(N2CCCC(CO)C2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3717821	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361123	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(N2CCCCC2CO)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3717442	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361124	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(N2CCCC(O)C2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3717483	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361125	CHEMBL3720912	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Cc1nc(N2CCC(O)CC2)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3718697	<	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361900	CHEMBL3720917	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	COc1ccc(-c2ncnc3[nH]c4ccc(O)cc4c23)cc1		CHEMBL3715855	<=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361901	CHEMBL3720917	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(-c4ccccc4)c3c2c1		CHEMBL3716507	<=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361902	CHEMBL3720917	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3nc(N)nc(-c4ccccc4)c3c2c1		CHEMBL3718666	<=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361903	CHEMBL3720917	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(-c4ccccc4)c3c2c1		CHEMBL3715348	<=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361904	CHEMBL3720917	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	Oc1ccc2[nH]c3ncnc(-c4ccc(F)cc4)c3c2c1		CHEMBL3716079	<=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361905	CHEMBL3720917	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	NC(=O)c1ccc2[nH]c3ncnc(-c4ccc(F)cc4)c3c2c1		CHEMBL3717353	<=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16361906	CHEMBL3720917	Inhibition of GST-tagged human MKK7 expressed in Escherichia coli (BL21(DE3) pLysS) co-expressing human MEKK catalytic domain using biotinylated and GST-tagged rat GST-KN-SAPKalpha substrate incubated for 1 hr by time-resolved fluorescence based assay	B	CN(C)c1ccc(-c2ncnc3[nH]c4ccc(C(N)=O)cc4c23)cc1		CHEMBL3716854	=	IC50	nM	1000.0	CHEMBL3530	Homo sapiens	IC50	uM	1.0
	16495132	CHEMBL3777495	Inhibition of N-terminal His6-tagged recombinant human MKK7beta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-33.0	CHEMBL3530	Homo sapiens	Activity	%	-33.0
	16496051	CHEMBL3777495	Inhibition of N-terminal His6-tagged recombinant human MKK7beta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-25.0	CHEMBL3530	Homo sapiens	Activity	%	-25.0
	16508238	CHEMBL3777495	Inhibition of N-terminal His6-tagged recombinant human MKK7beta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-15.0	CHEMBL3530	Homo sapiens	Activity	%	-15.0
	16737957	CHEMBL3856674	Inhibition of human MKK7beta assessed as remaining activity at 10 uM in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	111.0	CHEMBL3530	Homo sapiens	Activity	%	111.0
	18007228	CHEMBL4003436	Inhibition of full length human GST-HIS tagged MKK7 expressed in Sf9 cells assessed as residual activity at 1 uM relative to control	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4[nH]c(SC)nc4C)ccn3)cc2)c1		CHEMBL4082278	=	Activity	%	10.0	CHEMBL3530	Homo sapiens	Activity	%	10.0
	18020406	CHEMBL4005784	Inhibition of human N-terminal GST-tagged full length MAP2K7 expressed in baculovirus infected Sf21 insect cells in presence of 1 mM ATP	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	>	IC50	nM	50000.0	CHEMBL3530	Homo sapiens	IC50	nM	50000.0
	18114249	CHEMBL4025245	Inhibition of wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	18138933	CHEMBL4030446	Inhibition of MKK7beta (unknown origin) at 10 uM relative to control	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1		CHEMBL1773422	=	Inhibition	%	101.0	CHEMBL3530	Homo sapiens	INH	%	101.0
	18153287	CHEMBL4034378	Inhibition of MAP2K7 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	18.2	CHEMBL3530	Homo sapiens	INH	%	18.2
	18203769	CHEMBL4044056	Inhibition of wild-type human full length MKK7 (M1 to R419 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	18211681	CHEMBL4045738	Inhibition of MAP2K7 conserved Lys2 (DVKPSNILLDER) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	18.6	CHEMBL3530	Homo sapiens	INH	%	18.6
	18211883	CHEMBL4045979	Inhibition of MAP2K7 conserved Lys2 (DVKPSNILLDER) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	31.6	CHEMBL3530	Homo sapiens	INH	%	31.6
	18253855	CHEMBL4055212	Inhibition of wild-type human full length MAP2K7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	18253856	CHEMBL4055212	Inhibition of wild-type human full length MAP2K7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	55.0	CHEMBL3530	Homo sapiens	Activity	%	55.0
	18268997	CHEMBL4058128	Inhibition of recombinant human N-terminal GST-tagged MKK7beta (2 to end residues) expressed in Escherichia coli preincubated for 5 mins followed by substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay	B	C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4095253	=	IC50	nM	188.6	CHEMBL3530	Homo sapiens	IC50	nM	188.6
	18275040	CHEMBL4118392	Inhibition of MAP2K7 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DVKPSNILLDER probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	13.7	CHEMBL3530	Homo sapiens	INH	%	13.7
	18275041	CHEMBL4118392	Inhibition of MAP2K7 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DVKPSNILLDER probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	12.3	CHEMBL3530	Homo sapiens	INH	%	12.3
	18275042	CHEMBL4118392	Inhibition of MAP2K7 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DVKPSNILLDER probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	18.6	CHEMBL3530	Homo sapiens	INH	%	18.6
Active	18275816	CHEMBL4118776	Binding affinity to MAP2K7 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL3530	Homo sapiens	Activity		
Active	18275959	CHEMBL4118919	Binding affinity to MAP2K7 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL3530	Homo sapiens	Activity		
	18440311	CHEMBL4157135	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	18484267	CHEMBL4185914	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	18484751	CHEMBL4185914	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	90.0	CHEMBL3530	Homo sapiens	Activity	%	90.0
	18507702	CHEMBL4191062	Inhibition of recombinant human MKK7beta (2 to end residues) at 1 uM using inactive JNK171 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-4.0	CHEMBL3530	Homo sapiens	INH	%	-4.0
	18655421	CHEMBL4230814	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	18665401	CHEMBL4233358	Inhibition of MKK7 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL3530	Homo sapiens	IC50	nM	10000.0
	18674764	CHEMBL4235389	Inhibition of MKK7 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL3530	Homo sapiens	Ki	nM	2000.0
Not Determined	18674765	CHEMBL4235389	Inhibition of MKK7 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242		Ki			CHEMBL3530	Homo sapiens	Ki		
	18674766	CHEMBL4235389	Inhibition of MKK7 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	10000.0	CHEMBL3530	Homo sapiens	Ki	nM	10000.0
	18751994	CHEMBL4264403	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	18757991	CHEMBL4265591	Inhibition of MAP2K7 (unknown origin) in presence of 1 mM ATP concentration	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4281393	>	IC50	nM	10000.0	CHEMBL3530	Homo sapiens	IC50	nM	10000.0
	18757992	CHEMBL4265591	Inhibition of MAP2K7 (unknown origin) in presence of 1 mM ATP concentration	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(F)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4277610	>	IC50	nM	10000.0	CHEMBL3530	Homo sapiens	IC50	nM	10000.0
	18757993	CHEMBL4265591	Inhibition of MAP2K7 (unknown origin) in presence of 1 mM ATP concentration	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5cccc(CO)c5)c34)cc21		CHEMBL4292341	>	IC50	nM	10000.0	CHEMBL3530	Homo sapiens	IC50	nM	10000.0
	18761538	CHEMBL4266591	Inhibition of recombinant human N-terminal GST-tagged MKK7b (2 to end residues) expressed in Escherichia coli at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1	Outside typical range	CHEMBL4279192	=	Inhibition	%	-18.0	CHEMBL3530	Homo sapiens	INH	%	-18.0
	18761809	CHEMBL4266591	Inhibition of recombinant human N-terminal GST-tagged MKK7b (2 to end residues) expressed in Escherichia coli at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	14.0	CHEMBL3530	Homo sapiens	INH	%	14.0
	18761972	CHEMBL4266591	Inhibition of recombinant human N-terminal GST-tagged MKK7b (2 to end residues) expressed in Escherichia coli at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-7.0	CHEMBL3530	Homo sapiens	INH	%	-7.0
	18858067	CHEMBL4307913	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	88.0	CHEMBL3530	Homo sapiens	Activity	%	88.0
	18890548	CHEMBL4314169	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant by kinomescan method	B	O=C(O)CSC1=CC(=O)c2ccccc2C1=O		CHEMBL189010	=	Kd	nM	1400.0	CHEMBL3530	Homo sapiens	Kd	uM	1.4
	18890549	CHEMBL4314169	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant by kinomescan method	B	O=C1C(SCCO)=C(SCCO)C(=O)c2ccccc21		CHEMBL429095	=	Kd	nM	1100.0	CHEMBL3530	Homo sapiens	Kd	uM	1.1
	18890550	CHEMBL4314169	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant by kinomescan method	B	CC1=CC(=O)c2c(O)cccc2C1=O		CHEMBL295316	=	Kd	nM	14000.0	CHEMBL3530	Homo sapiens	Kd	uM	14.0
	18890551	CHEMBL4314169	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant by kinomescan method	B	O=C(O)CCSC1=CC(=O)c2ccccc2C1=O		CHEMBL100206	=	Kd	nM	230.0	CHEMBL3530	Homo sapiens	Kd	uM	0.23
	18890552	CHEMBL4314169	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant by kinomescan method	B	CC(SC1=CC(=O)c2ccccc2C1=O)C(=O)O		CHEMBL365781	=	Kd	nM	2100.0	CHEMBL3530	Homo sapiens	Kd	uM	2.1
	18890553	CHEMBL4314169	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant by kinomescan method	B	CC1=C(SCCC(=O)O)C(=O)c2ccccc2C1=O		CHEMBL492025	=	Kd	nM	15000.0	CHEMBL3530	Homo sapiens	Kd	uM	15.0
	18890554	CHEMBL4314169	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant by kinomescan method	B	CCSC1=C(C)C(=O)c2ccccc2C1=O		CHEMBL4450909	=	Kd	nM	13000.0	CHEMBL3530	Homo sapiens	Kd	uM	13.0
	18890555	CHEMBL4314169	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant by kinomescan method	B	COCCSC1=C(C)C(=O)c2ccccc2C1=O		CHEMBL4450216	=	Kd	nM	14000.0	CHEMBL3530	Homo sapiens	Kd	uM	14.0
	18890556	CHEMBL4314169	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant by kinomescan method	B	CC1=C(SC(C)C)C(=O)c2ccccc2C1=O		CHEMBL4559690	=	Kd	nM	13000.0	CHEMBL3530	Homo sapiens	Kd	uM	13.0
	18890557	CHEMBL4314169	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant by kinomescan method	B	CSC1=C(SC)C(=O)c2ccccc2C1=O		CHEMBL4452484	=	Kd	nM	4600.0	CHEMBL3530	Homo sapiens	Kd	uM	4.6
	18890558	CHEMBL4314169	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant by kinomescan method	B	COC1=C(OC)C(=O)c2ccccc2C1=O		CHEMBL402468	=	Kd	nM	27000.0	CHEMBL3530	Homo sapiens	Kd	uM	27.0
	18890559	CHEMBL4314169	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant by kinomescan method	B	O=C(O)c1cccc(NC2=C(Cl)C(=O)c3ccccc3C2=O)c1		CHEMBL1464721	=	Kd	nM	1900.0	CHEMBL3530	Homo sapiens	Kd	uM	1.9
Not Active	18890824	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O		CHEMBL9470		Activity			CHEMBL3530	Homo sapiens	Activity		
Not Active	18890825	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O		CHEMBL15193		Activity			CHEMBL3530	Homo sapiens	Activity		
Not Active	18890826	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	CC1=C(SCCO)C(=O)c2ccccc2C1=O		CHEMBL92659		Activity			CHEMBL3530	Homo sapiens	Activity		
Not Active	18890827	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	COc1ccc(OC)c2c1C(=O)C=C(SCCC(=O)O)C2=O		CHEMBL4517265		Activity			CHEMBL3530	Homo sapiens	Activity		
Not Active	18890828	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	COC1=CC(=O)c2ccccc2C1=O		CHEMBL106562		Activity			CHEMBL3530	Homo sapiens	Activity		
Not Active	18890829	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	COC1=C(C)C(=O)c2ccccc2C1=O		CHEMBL4551631		Activity			CHEMBL3530	Homo sapiens	Activity		
Not Active	18890830	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	CC1=CC(=O)c2ccccc2C1=O		CHEMBL590		Activity			CHEMBL3530	Homo sapiens	Activity		
Not Active	18890831	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	O=C1C(O)=C(CN(CCCl)CCCl)C(=O)c2ccccc21		CHEMBL1989970		Activity			CHEMBL3530	Homo sapiens	Activity		
Not Active	18890832	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	CC(C)(C)C1CCC(CC2=C(O)C(=O)c3ccccc3C2=O)CC1		CHEMBL3182074		Activity			CHEMBL3530	Homo sapiens	Activity		
Not Active	18890833	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	O=C(O)CNC1=C(Cl)C(=O)c2ccccc2C1=O		CHEMBL4551849		Inhibition	%		CHEMBL3530	Homo sapiens	INH		
Not Active	18890834	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	O=C(O)CCNC1=C(Cl)C(=O)c2ccccc2C1=O		CHEMBL4472186		Inhibition	%		CHEMBL3530	Homo sapiens	INH		
Not Active	18890835	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	O=C(O)CCCNC1=C(Cl)C(=O)c2ccccc2C1=O		CHEMBL4521861		Inhibition	%		CHEMBL3530	Homo sapiens	INH		
Not Active	18890836	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	O=C(O)CCCCCNC1=C(Cl)C(=O)c2ccccc2C1=O		CHEMBL4460881		Inhibition	%		CHEMBL3530	Homo sapiens	INH		
Not Active	18890837	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	O=C(O)c1ccc(NC2=C(Cl)C(=O)c3ccccc3C2=O)cc1		CHEMBL1578997		Inhibition	%		CHEMBL3530	Homo sapiens	INH		
Not Active	18890838	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	COC(=O)c1ccc(NC2=C(Cl)C(=O)c3ccccc3C2=O)cc1		CHEMBL4530313		Inhibition	%		CHEMBL3530	Homo sapiens	INH		
Not Active	18890839	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	O=C1C(Cl)=C(NCCO)C(=O)c2ccccc21		CHEMBL4554878		Inhibition	%		CHEMBL3530	Homo sapiens	INH		
Not Active	18890840	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	O=C1C(Cl)=C(NCCCO)C(=O)c2ccccc21		CHEMBL3199312		Inhibition	%		CHEMBL3530	Homo sapiens	INH		
Not Active	18890841	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	O=C1C(Cl)=C(NCCCN2CCOCC2)C(=O)c2ccccc21		CHEMBL1701309		Inhibition	%		CHEMBL3530	Homo sapiens	INH		
Not Active	18890842	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	COC(=O)c1ccc(NC2=C(N3CCCCC3)C(=O)c3ccccc3C2=O)cc1		CHEMBL4455362		Inhibition	%		CHEMBL3530	Homo sapiens	INH		
Not Active	18890843	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	COC(=O)c1ccc(NC2=C(OC)C(=O)c3ccccc3C2=O)cc1		CHEMBL4445325		Inhibition	%		CHEMBL3530	Homo sapiens	INH		
Not Active	18890883	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	O=C(O)CSc1nc(O)c2ccccc2n1		CHEMBL1731240		Activity			CHEMBL3530	Homo sapiens	Activity		
Not Active	18890884	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	O=C(O)CCCc1nc2ccccc2c(=O)[nH]1		CHEMBL3397958		Activity			CHEMBL3530	Homo sapiens	Activity		
Not Active	18890885	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	O=C(O)CCSc1nc(O)c2ccccc2n1		CHEMBL1334519		Activity			CHEMBL3530	Homo sapiens	Activity		
Not Active	18890886	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	Nn1c(CCC(=O)O)nc2ccccc2c1=O		CHEMBL4521230		Activity			CHEMBL3530	Homo sapiens	Activity		
Not Active	18890887	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	Cn1c(SCCC(=O)O)nc2ccccc2c1=O		CHEMBL4522976		Activity			CHEMBL3530	Homo sapiens	Activity		
Not Active	18890888	CHEMBL4314192	Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant at <30 uM by kinomescan method	B	O=C(O)CCNC(=O)Cn1cnc2ccccc2c1=O		CHEMBL4536023		Activity			CHEMBL3530	Homo sapiens	Activity		
	18919382	CHEMBL4322742	Binding affinity to recombinant human full-length N-terminal GST-tagged MAP2K7 (1 to 419 residues) expressed in baculovirus expression system using JNK2 as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	293.0	CHEMBL3530	Homo sapiens	Kd	nM	293.0
Not Determined	18919570	CHEMBL4322742	Binding affinity to recombinant human full-length N-terminal GST-tagged MAP2K7 (1 to 419 residues) expressed in baculovirus expression system using JNK2 as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489		Kd			CHEMBL3530	Homo sapiens	Kd		
	18938089	CHEMBL4327771	Inhibition of human MKK7 assessed as residual activity at 1 uM using JNK as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	97.5	CHEMBL3530	Homo sapiens	Activity	%	97.5
	18938090	CHEMBL4327771	Inhibition of human MKK7 assessed as residual activity at 1 uM using JNK as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	96.44	CHEMBL3530	Homo sapiens	Activity	%	96.44
	18938616	CHEMBL4328135	Inhibition of human MKK7 assessed as residual activity at 100 uM using JNK as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3530	Homo sapiens	Activity	%	65.0
	18938996	CHEMBL4328499	Inhibition of human MKK7 using JNK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1280.0	CHEMBL3530	Homo sapiens	IC50	10'-6M	1.28
	18958978	CHEMBL4333500	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	18964469	CHEMBL4335173	Inhibition of recombinant human MKK7beta (2 to end residues) assessed as residual activity at 1 uM using inactive JNK1a1 as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	93.0	CHEMBL3530	Homo sapiens	Activity	%	93.0
	19059691	CHEMBL4357992	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	96.0	CHEMBL3530	Homo sapiens	Activity	%	96.0
	19090256	CHEMBL4365830	Inhibition of wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	78.0	CHEMBL3530	Homo sapiens	Activity	%	78.0
	19092009	CHEMBL4366483	Inhibition of human MKK7 at 100 nM using JNK as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-2.26	CHEMBL3530	Homo sapiens	INH	%	-2.26
	19144651	CHEMBL4377667	Inhibition of recombinant human MKK7 (2 to end residues) at 1 uM using unactive JNK1a1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	35.0	CHEMBL3530	Homo sapiens	INH	%	35.0
	19147937	CHEMBL4379277	Inhibition of recombinant human MKK7 (2 to end residues) using inactive JNK1a1 as substrate incubated for 40 mins by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3530	Homo sapiens	IC50	uM	10.0
	19159519	CHEMBL4382623	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	77.0	CHEMBL3530	Homo sapiens	Activity	%	77.0
	19191488	CHEMBL4389342	Inhibition of wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	68.0	CHEMBL3530	Homo sapiens	INH	%	68.0
	19192005	CHEMBL4389819	Inhibition of wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	74.0	CHEMBL3530	Homo sapiens	INH	%	74.0
	19200261	CHEMBL4391445	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	19266505	CHEMBL4405455	Inhibition of wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3530	Homo sapiens	INH	%	50.0
	19276043	CHEMBL4408046	Inhibition of recombinant human MKK7beta (2 to end residues) at 1 uM using unactive JNK1a1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	13.0	CHEMBL3530	Homo sapiens	INH	%	13.0
Active	19485854	CHEMBL4481562	Covalent binding affinity to MKK7 (unknown origin) assessed as formation of covalent bond with Cys218 residues by MS/MS analysis	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475		Activity			CHEMBL3530	Homo sapiens	Activity		
Active	19485867	CHEMBL4481562	Covalent binding affinity to MKK7 (unknown origin) assessed as formation of covalent bond with Cys218 residues by MS/MS analysis	B	C#Cc1nn([C@@H]2CCCN(C(=O)C=C)C2)c2ncnc(N)c12		CHEMBL4071151		Activity			CHEMBL3530	Homo sapiens	Activity		
Active	19485894	CHEMBL4481562	Covalent binding affinity to MKK7 (unknown origin) assessed as formation of covalent bond with Cys218 residues by MS/MS analysis	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3cn(-c4ccc(C(C)=O)cc4)nn3)c3c(N)ncnc32)C1		CHEMBL4581088		Activity			CHEMBL3530	Homo sapiens	Activity		
	22423455	CHEMBL4674303	Inhibition of human MKK7 using JNK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	98.34	CHEMBL3530	Homo sapiens	Activity	%	98.34
	22423456	CHEMBL4674303	Inhibition of human MKK7 using JNK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	61.24	CHEMBL3530	Homo sapiens	Activity	%	61.24
	22441944	CHEMBL4678878	Inhibition of human recombinant MAPK27 using NK1a1 as substrate at 1 uM incubated for 40 mins in presence of [gamma32P]-ATP by scintillation counting method relative to control	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1		CHEMBL4462530	=	Inhibition	%	85.0	CHEMBL3530	Homo sapiens	INH	%	85.0
	22761803	CHEMBL4702206	Inhibition of MAP2K7 (unknown origin) using JNK peptide KFMMTPYVVTR incubated for 30 mins measured by multimode reader based ADP-glo assay	B	C#CCNC(=O)c1cc(NC(=O)C=C)cc(-c2n[nH]c3ccccc23)c1		CHEMBL4764965	=	IC50	nM	6.5	CHEMBL3530	Homo sapiens	IC50	nM	6.5
	22761804	CHEMBL4702206	Inhibition of MAP2K7 (unknown origin) using JNK peptide KFMMTPYVVTR incubated for 30 mins measured by multimode reader based ADP-glo assay	B	C=CC(=O)Nc1cccc(-c2n[nH]c3cc(C)ccc23)c1		CHEMBL4749823	=	IC50	nM	5.0	CHEMBL3530	Homo sapiens	IC50	nM	5.0
	22818116	CHEMBL4715339	Inhibition of recombinant human N-terminal GST-tagged MKK7beta1 (2 to end residues) expressed in Escherichia coli at 2 uM using JNK1alpha1/SAPK1c as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL3530	Homo sapiens	INH	%	50.0
	22843194	CHEMBL4720225	Inhibition of MKK7beta (unknown origin)	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	>	IC50	nM	10000.0	CHEMBL3530	Homo sapiens	IC50	nM	10000.0
	22843668	CHEMBL4720654	Inhibition of human MKK7 using JNK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	571.0	CHEMBL3530	Homo sapiens	IC50	10^-7M	5.71
	22844017	CHEMBL4721003	Inhibition of human MKK7 assessed as residual activity using JNK as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	89.92	CHEMBL3530	Homo sapiens	Activity	%	89.92
	22876507	CHEMBL4725965	Inhibition of MEK7 (unknown origin)	B	O=C(O)CCSC1=CC(=O)c2ccccc2C1=O		CHEMBL100206	=	IC50	nM	230.0	CHEMBL3530	Homo sapiens	IC50	nM	230.0
	22876508	CHEMBL4725965	Inhibition of MEK7 (unknown origin)	B	C=CC(=O)Nc1cccc(-c2n[nH]c3cc(C)ccc23)c1		CHEMBL4749823	=	IC50	nM	5.0	CHEMBL3530	Homo sapiens	IC50	nM	5.0
	22876509	CHEMBL4725965	Inhibition of MEK7 (unknown origin)	B	O=C(O)c1cccc(NC2=CC(=O)c3ccccc3C2=O)c1		CHEMBL3329977	=	IC50	nM	1.9	CHEMBL3530	Homo sapiens	IC50	nM	1.9
	22876510	CHEMBL4725965	Inhibition of MEK7 (unknown origin)	B	C=CC(=O)Nc1cccc(-c2n[nH]c3cc([N+](=O)[O-])ccc23)c1		CHEMBL4787266	=	IC50	nM	14.0	CHEMBL3530	Homo sapiens	IC50	nM	14.0
	22876511	CHEMBL4725965	Inhibition of MEK7 (unknown origin)	B	C=CC(=O)Nc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3901151	=	IC50	nM	6.0	CHEMBL3530	Homo sapiens	IC50	nM	6.0
	22926354	CHEMBL4737633	Inhibition of human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by kinome scan method relative to control	B	COc1ncc(-c2ccc3nccc(/C(C)=C/C(=O)N4CCN(C)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4739883	=	Activity	%	73.0	CHEMBL3530	Homo sapiens	Activity	%	73.0
	22953106	CHEMBL4767043	Inhibition of recombinant human MKK7beta using JNK1a1 as substrate incubated for 40 mins by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23120602	CHEMBL4804417	Inhibition of MAP2K7 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	15100.0	CHEMBL3530	Homo sapiens	IC50	uM	15.1
	23120603	CHEMBL4804417	Inhibition of MAP2K7 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-500.0	CHEMBL3530	Homo sapiens	IC50	uM	-0.5
	23120604	CHEMBL4804417	Inhibition of MAP2K7 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	86700.0	CHEMBL3530	Homo sapiens	IC50	uM	86.7
	23120605	CHEMBL4804417	Inhibition of MAP2K7 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	12200.0	CHEMBL3530	Homo sapiens	IC50	uM	12.2
	23120606	CHEMBL4804417	Inhibition of MAP2K7 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	3300.0	CHEMBL3530	Homo sapiens	IC50	uM	3.3
	23120607	CHEMBL4804417	Inhibition of MAP2K7 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	14600.0	CHEMBL3530	Homo sapiens	IC50	uM	14.6
	23121641	CHEMBL4804599	Inhibition of MAP2K7 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL3530	Homo sapiens	INH	%	0.0
	23121642	CHEMBL4804599	Inhibition of MAP2K7 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL3530	Homo sapiens	INH	%	0.0
	23121643	CHEMBL4804599	Inhibition of MAP2K7 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	75.0	CHEMBL3530	Homo sapiens	INH	%	75.0
	23121644	CHEMBL4804599	Inhibition of MAP2K7 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL3530	Homo sapiens	INH	%	0.0
	23121645	CHEMBL4804599	Inhibition of MAP2K7 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL3530	Homo sapiens	INH	%	0.0
	23121646	CHEMBL4804599	Inhibition of MAP2K7 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL3530	Homo sapiens	INH	%	0.0
	23122677	CHEMBL4805028	Inhibition of human MKK7 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	75.0	CHEMBL3530	Homo sapiens	Activity	%	75.0
	23123372	CHEMBL4805616	Inhibition of human MKK7 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	72.0	CHEMBL3530	Homo sapiens	Activity	%	72.0
	23123831	CHEMBL4806075	Inhibition of DNA-tagged human MKK7 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	75.0	CHEMBL3530	Homo sapiens	Activity	%	75.0
	23124834	CHEMBL4806633	Inhibition of human MKK7 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23124835	CHEMBL4806633	Inhibition of human MKK7 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	85.0	CHEMBL3530	Homo sapiens	Activity	%	85.0
	23128320	CHEMBL4807915	Inhibition of MKK7 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL3530	Homo sapiens	Activity	%	75.0
	23128321	CHEMBL4807915	Inhibition of MKK7 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL3530	Homo sapiens	Activity	%	75.0
	23128322	CHEMBL4807915	Inhibition of MKK7 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL3530	Homo sapiens	Activity	%	75.0
	23159817	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159818	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)nc23)c1F		CHEMBL4866813	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159819	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL4791205	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159820	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccccc4)cc23)c1F		CHEMBL4800472	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159821	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccccc4Cl)cc23)c1F		CHEMBL4783282	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159822	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4cccc(Cl)c4)cc23)c1F		CHEMBL4785446	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159823	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccccc4F)cc23)c1F		CHEMBL4783920	=	Activity	%	83.0	CHEMBL3530	Homo sapiens	Activity	%	83.0
	23159824	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4cccc(F)c4)cc23)c1F		CHEMBL4797028	=	Activity	%	97.0	CHEMBL3530	Homo sapiens	Activity	%	97.0
	23159825	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(F)cc4)cc23)c1F		CHEMBL4776558	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159826	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccccc4C)cc23)c1F		CHEMBL4781671	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159827	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4cccc(C)c4)cc23)c1F		CHEMBL4780014	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159828	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(C)cc4)cc23)c1F		CHEMBL4799314	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159829	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccccc4OC)cc23)c1F		CHEMBL4789177	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159830	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4cccc(OC)c4)cc23)c1F		CHEMBL4797810	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159831	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(OC)cc4)cc23)c1F		CHEMBL4779118	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159832	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccccc4O)cc23)c1F		CHEMBL4797354	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159833	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4cccc(O)c4)cc23)c1F		CHEMBL4796882	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159834	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(O)cc4)cc23)c1F		CHEMBL4792739	=	Activity	%	87.0	CHEMBL3530	Homo sapiens	Activity	%	87.0
	23159835	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccccc4N)cc23)c1F		CHEMBL4793562	=	Activity	%	95.0	CHEMBL3530	Homo sapiens	Activity	%	95.0
	23159836	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4cccc(N)c4)cc23)c1F		CHEMBL4797449	=	Activity	%	86.0	CHEMBL3530	Homo sapiens	Activity	%	86.0
	23159837	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(N)cc4)cc23)c1F		CHEMBL4785015	=	Activity	%	93.0	CHEMBL3530	Homo sapiens	Activity	%	93.0
	23159838	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4cccc(N(C)C)c4)cc23)c1F		CHEMBL4785982	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159839	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(N(C)C)cc4)cc23)c1F		CHEMBL4791513	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159840	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(Cl)cc4Cl)cc23)c1F		CHEMBL4790548	=	Activity	%	96.0	CHEMBL3530	Homo sapiens	Activity	%	96.0
	23159841	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4cc(Cl)cc(Cl)c4)cc23)c1F		CHEMBL4795496	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159842	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(Cl)c(Cl)c4)cc23)c1F		CHEMBL4787178	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159843	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(C)c(C)c4)cc23)c1F		CHEMBL4776410	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159844	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(C(C)C)cc4)cc23)c1F		CHEMBL4799932	=	Activity	%	98.0	CHEMBL3530	Homo sapiens	Activity	%	98.0
	23159845	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(C(C)(C)C)cc4)cc23)c1F		CHEMBL4796760	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159846	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(Cl)c(C(F)(F)F)c4)cc23)c1F		CHEMBL4777971	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159847	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(F)cc4C)cc23)c1F		CHEMBL4797964	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159848	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(OC)cc4Cl)cc23)c1F		CHEMBL4794368	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159849	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4cccc(C(F)(F)F)c4)cc23)c1F		CHEMBL4797202	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159850	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(C(F)(F)F)cc4)cc23)c1F		CHEMBL4794391	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159851	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4cccc([N+](=O)[O-])c4)cc23)c1F		CHEMBL4781410	=	Activity	%	95.0	CHEMBL3530	Homo sapiens	Activity	%	95.0
	23159852	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc([N+](=O)[O-])cc4)cc23)c1F		CHEMBL4783154	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159853	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(S(C)(=O)=O)cc4)cc23)c1F		CHEMBL4798539	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159854	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(S(N)(=O)=O)cc4)cc23)c1F		CHEMBL4784779	=	Activity	%	98.0	CHEMBL3530	Homo sapiens	Activity	%	98.0
	23159855	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(S(=O)(=O)NC)cc4)cc23)c1F		CHEMBL4779976	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159856	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(S(=O)(=O)NCC)cc4)cc23)c1F		CHEMBL4776483	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159857	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(S(=O)(=O)NC(C)=O)cc4)cc23)c1F		CHEMBL4790247	=	Activity	%	71.0	CHEMBL3530	Homo sapiens	Activity	%	71.0
	23159858	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(NS(C)(=O)=O)cc4)cc23)c1F		CHEMBL4782205	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159859	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(-c5nnn[nH]5)cc4)cc23)c1F		CHEMBL4779020	=	Activity	%	64.0	CHEMBL3530	Homo sapiens	Activity	%	64.0
	23159860	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(C(=O)O)cc4)cc23)c1F		CHEMBL4776399	=	Activity	%	27.0	CHEMBL3530	Homo sapiens	Activity	%	27.0
	23159861	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(C(N)=O)cc4)cc23)c1F		CHEMBL4797274	=	Activity	%	99.0	CHEMBL3530	Homo sapiens	Activity	%	99.0
	23159862	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(S(N)(=O)=O)cc4F)cc23)c1F		CHEMBL4793405	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159863	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(S(N)(=O)=O)cc4C)cc23)c1F		CHEMBL4859882	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159864	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(S(N)(=O)=O)cc4Cl)cc23)c1F		CHEMBL4788870	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159865	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(S(N)(=O)=O)cc4)cc23)c1F		CHEMBL4777904	=	Activity	%	99.0	CHEMBL3530	Homo sapiens	Activity	%	99.0
	23159866	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	CCCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(S(N)(=O)=O)cc4)cc23)c1F		CHEMBL4797480	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159867	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	NS(=O)(=O)c1ccc(-c2cnc3[nH]nc(C(=O)c4c(F)ccc(NS(=O)(=O)Cc5ccccc5)c4F)c3c2)cc1		CHEMBL4798975	=	Activity	%	99.0	CHEMBL3530	Homo sapiens	Activity	%	99.0
	23159868	CHEMBL4812262	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual binding level at 100 nM by Kinomescan method relative to control	B	Nc1ccc(-c2cnc3[nH]nc(C(=O)c4c(F)ccc(NS(=O)(=O)Cc5ccccc5)c4F)c3c2)cc1		CHEMBL4865410	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23159944	CHEMBL4812269	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system by Kinomescan method	B	NS(=O)(=O)c1ccc(-c2cnc3[nH]nc(C(=O)c4c(F)ccc(NS(=O)(=O)Cc5ccccc5)c4F)c3c2)cc1		CHEMBL4798975	=	Kd	nM	5000.0	CHEMBL3530	Homo sapiens	Kd	nM	5000.0
	23159945	CHEMBL4812269	Binding affinity to wild-type human full length MKK7 (M1 to R419 residues) expressed in mammalian expression system by Kinomescan method	B	Nc1ccc(-c2cnc3[nH]nc(C(=O)c4c(F)ccc(NS(=O)(=O)Cc5ccccc5)c4F)c3c2)cc1		CHEMBL4865410	=	Kd	nM	5000.0	CHEMBL3530	Homo sapiens	Kd	nM	5000.0
	23171897	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	Cc1nc(NC(C)CO)c2c(n1)[nH]c1ccc(O)cc12		CHEMBL3718941	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171898	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	Oc1ccc(-c2ncnc3[nH]c4ccc(O)cc4c23)cc1		CHEMBL4876366	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171899	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171900	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCC(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL4855333	=	Activity	%	94.0	CHEMBL3530	Homo sapiens	Activity	%	94.0
	23171901	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL4876248	=	Activity	%	87.0	CHEMBL3530	Homo sapiens	Activity	%	87.0
	23171902	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL4860851	=	Activity	%	89.0	CHEMBL3530	Homo sapiens	Activity	%	89.0
	23171903	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL4857038	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171904	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL4854686	=	Activity	%	89.0	CHEMBL3530	Homo sapiens	Activity	%	89.0
	23171905	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCCCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL4863946	=	Activity	%	81.0	CHEMBL3530	Homo sapiens	Activity	%	81.0
	23171906	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	O=C(c1c(F)ccc(NS(=O)(=O)CCCF)c1F)c1c[nH]c2ncc(-c3ccc(Cl)cc3)cc12		CHEMBL4856173	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171907	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	O=C(c1c(F)ccc(NS(=O)(=O)CCC(F)(F)F)c1F)c1c[nH]c2ncc(-c3ccc(Cl)cc3)cc12		CHEMBL4869002	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171908	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	COCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL4867419	=	Activity	%	75.0	CHEMBL3530	Homo sapiens	Activity	%	75.0
	23171909	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	O=C(c1c(F)ccc(NS(=O)(=O)c2ccccc2)c1F)c1c[nH]c2ncc(-c3ccc(Cl)cc3)cc12		CHEMBL4852271	=	Activity	%	83.0	CHEMBL3530	Homo sapiens	Activity	%	83.0
	23171910	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	O=C(c1c(F)ccc(NS(=O)(=O)Cc2ccccc2)c1F)c1c[nH]c2ncc(-c3ccc(Cl)cc3)cc12		CHEMBL4856688	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171911	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	O=C(c1c(F)ccc(NS(=O)(=O)CCc2ccccc2)c1F)c1c[nH]c2ncc(-c3ccc(Cl)cc3)cc12		CHEMBL4876500	=	Activity	%	97.0	CHEMBL3530	Homo sapiens	Activity	%	97.0
	23171912	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	O=C(c1c(F)ccc(NS(=O)(=O)Cc2ccc(F)cc2)c1F)c1c[nH]c2ncc(-c3ccc(Cl)cc3)cc12		CHEMBL4862074	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171913	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	O=C(c1c(F)ccc(NS(=O)(=O)Cc2cccc(F)c2)c1F)c1c[nH]c2ncc(-c3ccc(Cl)cc3)cc12		CHEMBL4862559	=	Activity	%	99.0	CHEMBL3530	Homo sapiens	Activity	%	99.0
	23171914	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	O=C(c1c(F)ccc(NS(=O)(=O)Cc2ccccc2F)c1F)c1c[nH]c2ncc(-c3ccc(Cl)cc3)cc12		CHEMBL4859059	=	Activity	%	97.0	CHEMBL3530	Homo sapiens	Activity	%	97.0
	23171915	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	Cc1ccc(CS(=O)(=O)Nc2ccc(F)c(C(=O)c3c[nH]c4ncc(-c5ccc(Cl)cc5)cc34)c2F)cc1		CHEMBL4864406	=	Activity	%	90.0	CHEMBL3530	Homo sapiens	Activity	%	90.0
	23171916	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	Cc1cccc(CS(=O)(=O)Nc2ccc(F)c(C(=O)c3c[nH]c4ncc(-c5ccc(Cl)cc5)cc34)c2F)c1		CHEMBL4878032	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171917	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccccc4)cc23)c1F		CHEMBL4209555	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171918	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	C#Cc1cnc2[nH]cc(C(=O)c3c(F)ccc(NS(=O)(=O)CCC)c3F)c2c1		CHEMBL3948349	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171919	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccco4)cc23)c1F		CHEMBL4846034	=	Activity	%	95.0	CHEMBL3530	Homo sapiens	Activity	%	95.0
	23171920	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cccs4)cc23)c1F		CHEMBL4857424	=	Activity	%	98.0	CHEMBL3530	Homo sapiens	Activity	%	98.0
	23171921	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cccc(Cl)c4)cc23)c1F		CHEMBL4858132	=	Activity	%	85.0	CHEMBL3530	Homo sapiens	Activity	%	85.0
	23171922	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccccc4Cl)cc23)c1F		CHEMBL4852621	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171923	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(F)cc4)cc23)c1F		CHEMBL4858068	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171924	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cccc(F)c4)cc23)c1F		CHEMBL4873441	=	Activity	%	90.0	CHEMBL3530	Homo sapiens	Activity	%	90.0
	23171925	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccccc4F)cc23)c1F		CHEMBL4869022	=	Activity	%	86.0	CHEMBL3530	Homo sapiens	Activity	%	86.0
	23171926	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(C)cc4)cc23)c1F		CHEMBL4856875	=	Activity	%	89.0	CHEMBL3530	Homo sapiens	Activity	%	89.0
	23171927	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cccc(C)c4)cc23)c1F		CHEMBL4876423	=	Activity	%	97.0	CHEMBL3530	Homo sapiens	Activity	%	97.0
	23171928	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccccc4C)cc23)c1F		CHEMBL4858031	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171929	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(OC)cc4)cc23)c1F		CHEMBL4870365	=	Activity	%	70.0	CHEMBL3530	Homo sapiens	Activity	%	70.0
	23171930	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cccc(OC)c4)cc23)c1F		CHEMBL4856185	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171931	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccccc4OC)cc23)c1F		CHEMBL4869172	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171932	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(F)cc4C)cc23)c1F		CHEMBL4876626	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171933	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(F)cc4F)cc23)c1F		CHEMBL4865366	=	Activity	%	93.0	CHEMBL3530	Homo sapiens	Activity	%	93.0
	23171934	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(F)cc4Cl)cc23)c1F		CHEMBL4874652	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171935	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(OC)cc4C)cc23)c1F		CHEMBL4860873	=	Activity	%	97.0	CHEMBL3530	Homo sapiens	Activity	%	97.0
	23171936	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(OC)cc4F)cc23)c1F		CHEMBL4850920	=	Activity	%	85.0	CHEMBL3530	Homo sapiens	Activity	%	85.0
	23171937	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(OC)cc4Cl)cc23)c1F		CHEMBL4878484	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171938	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(OC)c(OC)c4)cc23)c1F		CHEMBL4864523	=	Activity	%	84.0	CHEMBL3530	Homo sapiens	Activity	%	84.0
	23171939	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(OC)cc4OC)cc23)c1F		CHEMBL4871058	=	Activity	%	87.0	CHEMBL3530	Homo sapiens	Activity	%	87.0
	23171940	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc5c(c4)OCO5)cc23)c1F		CHEMBL4875631	=	Activity	%	90.0	CHEMBL3530	Homo sapiens	Activity	%	90.0
	23171941	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cc5c(cc4Cl)OCO5)cc23)c1F		CHEMBL4853117	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171942	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc5c(c4)OCCO5)cc23)c1F		CHEMBL4866246	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171943	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cc5c(cc4Cl)OCCO5)cc23)c1F		CHEMBL4875839	=	Activity	%	97.0	CHEMBL3530	Homo sapiens	Activity	%	97.0
	23171944	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cncnc4)cc23)c1F		CHEMBL3921859	=	Activity	%	81.0	CHEMBL3530	Homo sapiens	Activity	%	81.0
	23171945	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ncccn4)cc23)c1F		CHEMBL4874795	=	Activity	%	90.0	CHEMBL3530	Homo sapiens	Activity	%	90.0
	23171946	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cnccn4)cc23)c1F		CHEMBL4875951	=	Activity	%	83.0	CHEMBL3530	Homo sapiens	Activity	%	83.0
	23171947	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cnc(OC)nc4)cc23)c1F		CHEMBL4852709	=	Activity	%	84.0	CHEMBL3530	Homo sapiens	Activity	%	84.0
	23171948	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cnc(C5CC5)nc4)cc23)c1F		CHEMBL4878700	=	Activity	%	87.0	CHEMBL3530	Homo sapiens	Activity	%	87.0
	23171949	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1cccc(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1		CHEMBL4856677	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171950	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1cccc(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL4878023	=	Activity	%	92.0	CHEMBL3530	Homo sapiens	Activity	%	92.0
	23171951	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1cc(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)ccc1F		CHEMBL4872200	=	Activity	%	93.0	CHEMBL3530	Homo sapiens	Activity	%	93.0
	23171952	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1cc(F)cc(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1		CHEMBL4868690	=	Activity	%	93.0	CHEMBL3530	Homo sapiens	Activity	%	93.0
	23171953	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1		CHEMBL4850069	=	Activity	%	92.0	CHEMBL3530	Homo sapiens	Activity	%	92.0
	23171954	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1cccc(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1Cl		CHEMBL4854287	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171955	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CCCS(=O)(=O)Nc1cccc(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1C		CHEMBL4858391	=	Activity	%	91.0	CHEMBL3530	Homo sapiens	Activity	%	91.0
	23171956	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	CS(=O)(=O)Nc1cccc(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL4846221	=	Activity	%	81.0	CHEMBL3530	Homo sapiens	Activity	%	81.0
	23171957	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	O=C(c1cccc(NS(=O)(=O)Cc2ccccc2)c1F)c1c[nH]c2ncc(-c3ccc(Cl)cc3)cc12		CHEMBL4874545	=	Activity	%	97.0	CHEMBL3530	Homo sapiens	Activity	%	97.0
	23171958	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	COc1ccc(-c2cnc3[nH]cc(C(=O)c4cccc(NS(=O)(=O)Cc5ccccc5)c4F)c3c2)c(Cl)c1		CHEMBL4864124	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171959	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	Cc1cc(F)ccc1-c1cnc2[nH]cc(C(=O)c3cccc(NS(=O)(=O)Cc4ccccc4)c3F)c2c1		CHEMBL4872509	=	Activity	%	98.0	CHEMBL3530	Homo sapiens	Activity	%	98.0
	23171960	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	O=C(c1cccc(NS(=O)(=O)Cc2ccccc2)c1F)c1c[nH]c2ncc(-c3cc4c(cc3Cl)OCO4)cc12		CHEMBL4863128	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171961	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	O=C(c1cccc(NS(=O)(=O)Cc2ccccc2)c1F)c1c[nH]c2ncc(-c3cc4c(cc3Cl)OCCO4)cc12		CHEMBL4868537	=	Activity	%	100.0	CHEMBL3530	Homo sapiens	Activity	%	100.0
	23171962	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	O=C(c1cccc(NS(=O)(=O)Cc2ccccc2)c1F)c1c[nH]c2ncc(-c3ccncc3)cc12		CHEMBL4866918	=	Activity	%	95.0	CHEMBL3530	Homo sapiens	Activity	%	95.0
	23171963	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	O=C(c1cccc(NS(=O)(=O)Cc2ccccc2)c1F)c1c[nH]c2ncc(-c3cccnc3)cc12		CHEMBL4853565	=	Activity	%	85.0	CHEMBL3530	Homo sapiens	Activity	%	85.0
	23171964	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	COc1ncc(-c2cnc3[nH]cc(C(=O)c4cccc(NS(=O)(=O)Cc5ccccc5)c4F)c3c2)cn1		CHEMBL4848804	=	Activity	%	70.0	CHEMBL3530	Homo sapiens	Activity	%	70.0
	23171965	CHEMBL4814584	Binding affinity to wild type full length human MKK7 (M1 to R419 residues) expressed in mammalian expression system assessed as residual activity at 100 nM measured by Kinomescan assay	B	O=C(c1cccc(NS(=O)(=O)Cc2ccccc2)c1F)c1c[nH]c2ncc(-c3cnc(C4CC4)nc3)cc12		CHEMBL4857316	=	Activity	%	86.0	CHEMBL3530	Homo sapiens	Activity	%	86.0
	23294369	CHEMBL4840155	Inhibition of human recombinant full length N-terminal GST tagged MEK7 expressed in Sf21 cells using JNK1 as substrate pre-incubated for 30 mins followed by addition of ATP and measured after 150 mins by ADP-Glo kinase assay	B	NS(=O)(=O)c1ccc(-c2n[nH]c3cc(F)ccc23)cc1		CHEMBL4879048	=	IC50	nM	540.0	CHEMBL3530	Homo sapiens	IC50	uM	0.54
	23294370	CHEMBL4840155	Inhibition of human recombinant full length N-terminal GST tagged MEK7 expressed in Sf21 cells using JNK1 as substrate pre-incubated for 30 mins followed by addition of ATP and measured after 150 mins by ADP-Glo kinase assay	B	O=S(=O)(Nc1ccc(-c2n[nH]c3cc(F)ccc23)cc1)c1cccnc1		CHEMBL4875241	=	IC50	nM	2700.0	CHEMBL3530	Homo sapiens	IC50	uM	2.7
	23294371	CHEMBL4840155	Inhibition of human recombinant full length N-terminal GST tagged MEK7 expressed in Sf21 cells using JNK1 as substrate pre-incubated for 30 mins followed by addition of ATP and measured after 150 mins by ADP-Glo kinase assay	B	O=S(=O)(Nc1cccc(-c2n[nH]c3cc(F)ccc23)c1)c1cccnc1		CHEMBL4871202	=	IC50	nM	1300.0	CHEMBL3530	Homo sapiens	IC50	uM	1.3
	23294372	CHEMBL4840155	Inhibition of human recombinant full length N-terminal GST tagged MEK7 expressed in Sf21 cells using JNK1 as substrate pre-incubated for 30 mins followed by addition of ATP and measured after 150 mins by ADP-Glo kinase assay	B	O=S(=O)(Nc1cccc(-c2n[nH]c3cc(F)ccc23)c1)C1CC1		CHEMBL4871178	=	IC50	nM	6400.0	CHEMBL3530	Homo sapiens	IC50	uM	6.4
	23294373	CHEMBL4840155	Inhibition of human recombinant full length N-terminal GST tagged MEK7 expressed in Sf21 cells using JNK1 as substrate pre-incubated for 30 mins followed by addition of ATP and measured after 150 mins by ADP-Glo kinase assay	B	O=S(=O)(NC1CC1)c1ccc(-c2n[nH]c3cc(F)ccc23)cc1		CHEMBL4871476	=	IC50	nM	8700.0	CHEMBL3530	Homo sapiens	IC50	uM	8.7
	23294374	CHEMBL4840155	Inhibition of human recombinant full length N-terminal GST tagged MEK7 expressed in Sf21 cells using JNK1 as substrate pre-incubated for 30 mins followed by addition of ATP and measured after 150 mins by ADP-Glo kinase assay	B	O=S(=O)(Nc1ccccc1)c1cccc(-c2n[nH]c3cc(F)ccc23)c1		CHEMBL4872723	=	IC50	nM	840.0	CHEMBL3530	Homo sapiens	IC50	uM	0.84
	23294375	CHEMBL4840155	Inhibition of human recombinant full length N-terminal GST tagged MEK7 expressed in Sf21 cells using JNK1 as substrate pre-incubated for 30 mins followed by addition of ATP and measured after 150 mins by ADP-Glo kinase assay	B	CC(C)Oc1ccc(NS(=O)(=O)c2cccc(-c3n[nH]c4cc(F)ccc34)c2)cc1		CHEMBL4875961	=	IC50	nM	2900.0	CHEMBL3530	Homo sapiens	IC50	uM	2.9
	23294376	CHEMBL4840155	Inhibition of human recombinant full length N-terminal GST tagged MEK7 expressed in Sf21 cells using JNK1 as substrate pre-incubated for 30 mins followed by addition of ATP and measured after 150 mins by ADP-Glo kinase assay	B	CS(=O)(=O)c1ccc(NS(=O)(=O)c2cccc(-c3n[nH]c4cc(F)ccc34)c2)cc1		CHEMBL4865159	=	IC50	nM	920.0	CHEMBL3530	Homo sapiens	IC50	uM	0.92
	23294377	CHEMBL4840155	Inhibition of human recombinant full length N-terminal GST tagged MEK7 expressed in Sf21 cells using JNK1 as substrate pre-incubated for 30 mins followed by addition of ATP and measured after 150 mins by ADP-Glo kinase assay	B	CC(=O)c1ccc(NS(=O)(=O)c2cccc(-c3n[nH]c4cc(F)ccc34)c2)cc1		CHEMBL4875545	=	IC50	nM	1300.0	CHEMBL3530	Homo sapiens	IC50	uM	1.3
	23294378	CHEMBL4840155	Inhibition of human recombinant full length N-terminal GST tagged MEK7 expressed in Sf21 cells using JNK1 as substrate pre-incubated for 30 mins followed by addition of ATP and measured after 150 mins by ADP-Glo kinase assay	B	NC(=O)c1ccc(NS(=O)(=O)c2cccc(-c3n[nH]c4cc(F)ccc34)c2)cc1		CHEMBL4866649	=	IC50	nM	96.0	CHEMBL3530	Homo sapiens	IC50	uM	0.096
	23294397	CHEMBL4840161	Inhibition of human wild type full length MEK7 (M1 to R417 residues) expressed in mammalian expression system at 1 uM measured by Kinomescan assay	B	NS(=O)(=O)c1ccc(-c2n[nH]c3cc(F)ccc23)cc1		CHEMBL4879048	=	Inhibition	%	58.0	CHEMBL3530	Homo sapiens	INH	%	58.0
	23294398	CHEMBL4840161	Inhibition of human wild type full length MEK7 (M1 to R417 residues) expressed in mammalian expression system at 1 uM measured by Kinomescan assay	B	NC(=O)c1ccc(NS(=O)(=O)c2cccc(-c3n[nH]c4cc(F)ccc34)c2)cc1		CHEMBL4866649	=	Inhibition	%	74.0	CHEMBL3530	Homo sapiens	INH	%	74.0
	23294407	CHEMBL4840166	Inhibition of human wild type full length MEK7 (M1 to R417 residues) expressed in mammalian expression system at 10 uM measured by Kinomescan assay	B	NS(=O)(=O)c1ccc(-c2n[nH]c3cc(F)ccc23)cc1		CHEMBL4879048	=	Inhibition	%	79.0	CHEMBL3530	Homo sapiens	INH	%	79.0
	23294408	CHEMBL4840166	Inhibition of human wild type full length MEK7 (M1 to R417 residues) expressed in mammalian expression system at 10 uM measured by Kinomescan assay	B	NC(=O)c1ccc(NS(=O)(=O)c2cccc(-c3n[nH]c4cc(F)ccc34)c2)cc1		CHEMBL4866649	=	Inhibition	%	99.0	CHEMBL3530	Homo sapiens	INH	%	99.0
Not Active	23294447	CHEMBL4840189	Inhibition of human MEK7 in human HEK293T cells assessed as decrease of MEK7 expression in presence of anisomycin at 100 uM measured after 5 hrs by Western blot assay	B	NS(=O)(=O)c1ccc(-c2n[nH]c3cc(F)ccc23)cc1		CHEMBL4879048		Inhibition	%		CHEMBL3530	Homo sapiens	INH		
Not Active	23294448	CHEMBL4840189	Inhibition of human MEK7 in human HEK293T cells assessed as decrease of MEK7 expression in presence of anisomycin at 100 uM measured after 5 hrs by Western blot assay	B	NC(=O)c1ccc(NS(=O)(=O)c2cccc(-c3n[nH]c4cc(F)ccc34)c2)cc1		CHEMBL4866649		Inhibition	%		CHEMBL3530	Homo sapiens	INH		
Not Active	23317512	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	79.0	CHEMBL3530	Homo sapiens	% Control	%	79.0
Not Active	23317980	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23318647	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23319130	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	96.0	CHEMBL3530	Homo sapiens	% Control	%	96.0
Not Active	23319767	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	90.8	CHEMBL3530	Homo sapiens	% Control	%	90.8
Not Active	23320242	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	88.6	CHEMBL3530	Homo sapiens	% Control	%	88.6
Not Active	23320920	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23321388	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	92.0	CHEMBL3530	Homo sapiens	% Control	%	92.0
Not Active	23322018	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	74.0	CHEMBL3530	Homo sapiens	% Control	%	74.0
Not Active	23322486	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	91.0	CHEMBL3530	Homo sapiens	% Control	%	91.0
Not Active	23323175	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	88.0	CHEMBL3530	Homo sapiens	% Control	%	88.0
Not Active	23323643	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23324061	CHEMBL4880680	MKK7beta (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	13.0	CHEMBL3530	Homo sapiens	% inhibition	%	13.0
Not Active	23324497	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	92.2	CHEMBL3530	Homo sapiens	% Control	%	92.2
Not Active	23325132	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	96.0	CHEMBL3530	Homo sapiens	% Control	%	96.0
Not Active	23325600	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	89.0	CHEMBL3530	Homo sapiens	% Control	%	89.0
Not Active	23326247	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	91.0	CHEMBL3530	Homo sapiens	% Control	%	91.0
Not Active	23326715	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23327415	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	72.0	CHEMBL3530	Homo sapiens	% Control	%	72.0
Not Active	23327883	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	79.0	CHEMBL3530	Homo sapiens	% Control	%	79.0
Not Active	23328470	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	79.0	CHEMBL3530	Homo sapiens	% Control	%	79.0
Not Active	23328938	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23329422	CHEMBL4881129	MKK7beta (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	106.0	CHEMBL3530	Homo sapiens	% residual kinase activity	%	106.0
Not Active	23329884	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23330352	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	86.0	CHEMBL3530	Homo sapiens	% Control	%	86.0
Not Active	23331108	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23331576	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23332163	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	70.8	CHEMBL3530	Homo sapiens	% Control	%	70.8
Not Active	23332629	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	89.7	CHEMBL3530	Homo sapiens	% Control	%	89.7
Not Active	23333347	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23333986	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	79.0	CHEMBL3530	Homo sapiens	% Control	%	79.0
Not Active	23334454	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	81.0	CHEMBL3530	Homo sapiens	% Control	%	81.0
Not Active	23334920	CHEMBL4881543	MKK7beta(h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	20.0	CHEMBL3530	Homo sapiens	% inhibition	%	20.0
Not Active	23335433	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	67.0	CHEMBL3530	Homo sapiens	% Control	%	67.0
Not Active	23335901	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	84.0	CHEMBL3530	Homo sapiens	% Control	%	84.0
Not Active	23336528	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	95.0	CHEMBL3530	Homo sapiens	% Control	%	95.0
Not Active	23336996	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23338077	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	94.0	CHEMBL3530	Homo sapiens	% Control	%	94.0
Not Active	23338545	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	87.0	CHEMBL3530	Homo sapiens	% Control	%	87.0
Not Active	23339157	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	99.0	CHEMBL3530	Homo sapiens	% Control	%	99.0
Not Active	23339625	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	99.0	CHEMBL3530	Homo sapiens	% Control	%	99.0
Not Active	23340262	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	91.0	CHEMBL3530	Homo sapiens	% Control	%	91.0
Not Active	23340730	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23341387	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	86.0	CHEMBL3530	Homo sapiens	% Control	%	86.0
Not Active	23341855	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23342471	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	82.0	CHEMBL3530	Homo sapiens	% Control	%	82.0
Not Active	23342939	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	98.0	CHEMBL3530	Homo sapiens	% Control	%	98.0
Not Active	23343569	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	97.0	CHEMBL3530	Homo sapiens	% Control	%	97.0
Not Active	23344037	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	95.0	CHEMBL3530	Homo sapiens	% Control	%	95.0
Not Active	23344675	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	85.0	CHEMBL3530	Homo sapiens	% Control	%	85.0
Not Active	23345248	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	81.0	CHEMBL3530	Homo sapiens	% Control	%	81.0
Not Active	23345716	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	91.0	CHEMBL3530	Homo sapiens	% Control	%	91.0
Not Active	23346293	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	90.3	CHEMBL3530	Homo sapiens	% Control	%	90.3
Not Active	23346761	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	77.8	CHEMBL3530	Homo sapiens	% Control	%	77.8
Not Active	23347363	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	89.4	CHEMBL3530	Homo sapiens	% Control	%	89.4
Not Active	23347853	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	94.1	CHEMBL3530	Homo sapiens	% Control	%	94.1
Not Active	23348432	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23348900	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23349487	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23350105	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23350573	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23351178	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	89.0	CHEMBL3530	Homo sapiens	% Control	%	89.0
Not Active	23351646	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23352670	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	77.0	CHEMBL3530	Homo sapiens	% Control	%	77.0
Not Active	23353138	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	74.0	CHEMBL3530	Homo sapiens	% Control	%	74.0
Not Active	23354020	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23354488	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23355220	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	95.0	CHEMBL3530	Homo sapiens	% Control	%	95.0
Not Active	23355688	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	79.0	CHEMBL3530	Homo sapiens	% Control	%	79.0
Not Active	23356324	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23356792	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23357401	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23358048	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23358516	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	91.0	CHEMBL3530	Homo sapiens	% Control	%	91.0
Not Active	23359102	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	81.2	CHEMBL3530	Homo sapiens	% Control	%	81.2
Not Active	23359700	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	72.0	CHEMBL3530	Homo sapiens	% Control	%	72.0
Not Active	23360168	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	99.0	CHEMBL3530	Homo sapiens	% Control	%	99.0
Not Active	23360753	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	98.0	CHEMBL3530	Homo sapiens	% Control	%	98.0
Not Active	23361221	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23361794	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	64.0	CHEMBL3530	Homo sapiens	% Control	%	64.0
Not Active	23362330	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23362798	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23364440	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23364908	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23365647	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	69.0	CHEMBL3530	Homo sapiens	% Control	%	69.0
Not Active	23366190	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23366780	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	99.0	CHEMBL3530	Homo sapiens	% Control	%	99.0
Not Active	23367248	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23368126	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	95.0	CHEMBL3530	Homo sapiens	% Control	%	95.0
Not Active	23368594	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23369193	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	92.0	CHEMBL3530	Homo sapiens	% Control	%	92.0
Not Active	23369661	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23370141	CHEMBL4884385	MKK7beta(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	103.0	CHEMBL3530	Homo sapiens	% residual kinase activity	%	103.0
Not Active	23370629	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23371097	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	65.0	CHEMBL3530	Homo sapiens	% Control	%	65.0
Not Active	23371906	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	95.0	CHEMBL3530	Homo sapiens	% Control	%	95.0
Not Active	23372374	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
	23373728	CHEMBL4885505	MAP2K7(M2K7CGRI) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3530	Homo sapiens	pIC50		6.0
Not Active	23375307	CHEMBL4886289	mitogen-activated protein kinase kinase 7 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1	Outside typical range	CHEMBL2180408		Inhibition	%	-11.0	CHEMBL3530	Homo sapiens	% inhibition	%	-11.0
Not Active	23375801	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23376269	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23376846	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	93.0	CHEMBL3530	Homo sapiens	% Control	%	93.0
Not Active	23377314	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	87.0	CHEMBL3530	Homo sapiens	% Control	%	87.0
Not Active	23378174	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	97.0	CHEMBL3530	Homo sapiens	% Control	%	97.0
Not Active	23378642	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	85.0	CHEMBL3530	Homo sapiens	% Control	%	85.0
Not Active	23379809	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	95.0	CHEMBL3530	Homo sapiens	% Control	%	95.0
Not Active	23380277	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23380971	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	79.0	CHEMBL3530	Homo sapiens	% Control	%	79.0
Not Active	23381619	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23382087	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23382711	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	97.0	CHEMBL3530	Homo sapiens	% Control	%	97.0
Not Active	23383179	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	73.0	CHEMBL3530	Homo sapiens	% Control	%	73.0
Not Active	23385094	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
Not Active	23385561	CHEMBL4879818	KinomeScan assay: inhibition of MKK7	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL3530	Homo sapiens	% Control	%	100.0
